<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26628268</article-id><article-id pub-id-type="pmc">4666048</article-id><article-id pub-id-type="publisher-id">1059</article-id><article-id pub-id-type="doi">10.1186/s13063-015-1059-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Internet-based cognitive behavioural therapy (iCBT) for posttraumatic stress disorder versus waitlist control: study protocol for a randomised controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Allen</surname><given-names>Adrian R.</given-names></name><address><phone>(+612) 8382 1400</phone><email>adrian.allen@unsw.edu.au</email></address><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Newby</surname><given-names>Jill M.</given-names></name><address><email>j.newby@unsw.edu.au</email></address><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Jessica</given-names></name><address><email>Jessica.smith@svha.org.au</email></address><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Andrews</surname><given-names>Gavin</given-names></name><address><email>gavina@unsw.edu.au</email></address><xref ref-type="aff" rid="Aff1"></xref></contrib><aff id="Aff1">Clinical Research Unit for Anxiety and Depression, School of Psychiatry, University of New South Wales at St Vincent’s Hospital, Level 4, O’Brien Centre, St. Vincent’s Hospital, 394-404 Victoria Street, Darlinghurst, NSW Australia </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>16</volume><elocation-id>544</elocation-id><history><date date-type="received"><day>23</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>© Allen et al. 2015</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><offsets xml_i="3700" xml_f="3710" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3721" xml_f="4076" txt_i="22" txt_f="377">This randomised controlled trial (RCT) with two parallel arms will evaluate the efficacy of an internet-delivered six-lesson 10-week cognitive behavioural therapy (iCBT) intervention for posttraumatic stress disorder (PTSD). It will also investigate the association between changes in PTSD symptoms, intolerance of uncertainty (IU) and emotion regulation.</offsets></p></sec><sec><title><offsets xml_i="4098" xml_f="4112" txt_i="379" txt_f="393">Methods/Design</offsets></title><p><offsets xml_i="4123" xml_f="4373" txt_i="394" txt_f="644">Patients with PTSD will be recruited via the research arm of a not-for-profit clinical and research unit in Australia and randomised to a treatment group or waitlist control group. The minimum sample size for each group (alpha 0.05, power 0.80 for a </offsets><italic><offsets xml_i="4381" xml_f="4382" txt_i="644" txt_f="645">g</offsets></italic><offsets xml_i="4391" xml_f="5599" txt_i="645" txt_f="1853"> of 0.47) was identified as 72, but 10 % more will be recruited to hedge against expected attrition. PTSD diagnosis will be determined using the PTSD module from the Mini International Neuropsychiatric Interview version 5.0.0. The PTSD Checklist – Civilian version (PCL-C) will be used to measure PTSD symptoms (the primary outcome measure), with the Intolerance of Uncertainty Scale 12-item version (IUS-12) and the Emotion Regulation Questionnaire (ERQ) used to measure intolerance of uncertainty and emotion regulation, respectively. The PCL-C will be administered to the treatment group before each lesson of the PTSD program and at 3-month follow-up. The IUS-12 and ERQ will be administered before lessons 1 and 4, at post-treatment and at 3-month follow-up. The waitlist control group will complete these measures at week 1, week 5 and week 11 of the waitlist period. PTSD program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at 3-month follow-up. Mediation analyses using PROCESS will be used to examine the association between change in PTSD symptoms over treatment and change in each of IU and emotion regulation ability in separate analyses.</offsets></p></sec><sec><title><offsets xml_i="5621" xml_f="5631" txt_i="1855" txt_f="1865">Discussion</offsets></title><p><offsets xml_i="5642" xml_f="5924" txt_i="1866" txt_f="2148">The current RCT seeks to replicate previous efficacy findings of iCBT for PTSD in a formally assessed PTSD sample from the general population. Findings may point to future lines of enquiry for the role of IU and emotion regulation in the mechanism of PTSD symptom change during CBT.</offsets></p></sec><sec><title><offsets xml_i="5946" xml_f="5964" txt_i="2150" txt_f="2168">Trial registration</offsets></title><p><offsets xml_i="5975" xml_f="6024" txt_i="2169" txt_f="2218">Australian New Zealand Clinical Trials Registry: </offsets><ext-link ext-link-type="uri" xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366115&amp;isReview=true"><offsets xml_i="6157" xml_f="6176" txt_i="2218" txt_f="2237">ACTRN12614001213639</offsets></ext-link><offsets xml_i="6187" xml_f="6359" txt_i="2237" txt_f="2409">, registered 18 November 2014. This trial protocol is written in compliance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.</offsets></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Internet cognitive behavioural therapy</kwd><kwd>Posttraumatic stress disorder</kwd><kwd>Randomised controlled trial</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title><offsets xml_i="6801" xml_f="6811" txt_i="2418" txt_f="2428">Background</offsets></title><p><offsets xml_i="6822" xml_f="7185" txt_i="2429" txt_f="2792">Posttraumatic stress disorder (PTSD) can follow experiencing a traumatic event in which the individual experiences or witnesses severe threat to life or physical safety. It is characterised by recurrent intrusive thoughts or memories of the traumatic event, avoidance of trauma reminders, elevated physiological arousal and negative changes in thoughts and mood [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="7217" xml_f="7218" txt_i="2792" txt_f="2793">1</offsets></xref><offsets xml_i="7225" xml_f="7308" txt_i="2793" txt_f="2876">]. The lifetime prevalence of PTSD is approximately 7 % in the general population [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="7340" xml_f="7341" txt_i="2876" txt_f="2877">2</offsets></xref><offsets xml_i="7348" xml_f="7349" txt_i="2877" txt_f="2878">–</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="7381" xml_f="7382" txt_i="2878" txt_f="2879">4</offsets></xref><offsets xml_i="7389" xml_f="7501" txt_i="2879" txt_f="2991">]. It has a chronic course when untreated – up to one third of those with PTSD remain symptomatic for 30 years [</offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="7533" xml_f="7534" txt_i="2991" txt_f="2992">5</offsets></xref><offsets xml_i="7541" xml_f="7826" txt_i="2992" txt_f="3277">]. The impact of the disorder on the individual is significant. Compared to those without the disorder, PTSD is independently associated with: greater prevalence of physical health conditions, such as respiratory disease, cardiovascular disease, cancer and gastrointestinal illnesses [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="7858" xml_f="7859" txt_i="3277" txt_f="3278">6</offsets></xref><offsets xml_i="7866" xml_f="7878" txt_i="3278" txt_f="3290">], but see [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="7910" xml_f="7911" txt_i="3290" txt_f="3291">7</offsets></xref><offsets xml_i="7918" xml_f="8014" txt_i="3291" txt_f="3387">]; increased comorbidity of mental health conditions, such as anxiety disorders and depression [</offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="8046" xml_f="8047" txt_i="3387" txt_f="3388">8</offsets></xref><offsets xml_i="8054" xml_f="8099" txt_i="3388" txt_f="3433">]; and increased risk of suicidal behaviour [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="8131" xml_f="8132" txt_i="3433" txt_f="3434">9</offsets></xref><offsets xml_i="8139" xml_f="8284" txt_i="3434" txt_f="3579">]. Taken together, these data indicate a significant individual impact from the disorder, as well as societal cost in terms of burden of disease.</offsets></p><p><offsets xml_i="8291" xml_f="8440" txt_i="3580" txt_f="3729">Cognitive behavioural therapy (CBT) is the psychological treatment of choice for PTSD and is recommended by best-practice treatment guidelines e.g. [</offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="8473" xml_f="8475" txt_i="3729" txt_f="3731">10</offsets></xref><offsets xml_i="8482" xml_f="8484" txt_i="3731" txt_f="3733">, </offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="8517" xml_f="8519" txt_i="3733" txt_f="3735">11</offsets></xref><offsets xml_i="8526" xml_f="8890" txt_i="3735" txt_f="4099">]. CBT typically involves confrontation with, and processing of, the trauma memory in a safe, gradual manner; identification and restructuring of problematic beliefs; and dearousal skills. There is strong research evidence for use of these CBT techniques to treat PTSD in terms of magnitude of symptom reduction from pre-treatment levels, and diagnostic recovery [</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="8923" xml_f="8925" txt_i="4099" txt_f="4101">12</offsets></xref><offsets xml_i="8932" xml_f="8933" txt_i="4101" txt_f="4102">–</offsets><xref ref-type="bibr" rid="CR15"><offsets xml_i="8966" xml_f="8968" txt_i="4102" txt_f="4104">15</offsets></xref><offsets xml_i="8975" xml_f="9162" txt_i="4104" txt_f="4291">]. Despite this evidence, those with PTSD are an underserviced population. The majority of those with PTSD do not seek treatment and those seeking treatment do so with significant delay [</offsets><xref ref-type="bibr" rid="CR16"><offsets xml_i="9195" xml_f="9197" txt_i="4291" txt_f="4293">16</offsets></xref><offsets xml_i="9204" xml_f="9310" txt_i="4293" txt_f="4399">]. Associated treatment barriers include stigma, cost, geography and insufficient treatment availability [</offsets><xref ref-type="bibr" rid="CR17"><offsets xml_i="9343" xml_f="9345" txt_i="4399" txt_f="4401">17</offsets></xref><offsets xml_i="9352" xml_f="9379" txt_i="4401" txt_f="4428">]. Indeed, McLean and Foa [</offsets><xref ref-type="bibr" rid="CR17"><offsets xml_i="9412" xml_f="9414" txt_i="4428" txt_f="4430">17</offsets></xref><offsets xml_i="9421" xml_f="9574" txt_i="4430" txt_f="4583">] have noted that development of effective and efficient delivery systems for evidence-based PTSD treatments remains a key challenge in the trauma field.</offsets></p><p><offsets xml_i="9581" xml_f="9937" txt_i="4584" txt_f="4940">Attempting to counter these difficulties, recent efforts have examined internet-based delivery of empirically supported treatment for PTSD symptomatology. Clinical research has shown that internet-based delivery of cognitive behavioural therapy (iCBT) has utility for treating PTSD symptoms to an extent approximately equivalent to face-to-face treatment [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="9970" xml_f="9972" txt_i="4940" txt_f="4942">18</offsets></xref><offsets xml_i="9979" xml_f="9980" txt_i="4942" txt_f="4943">–</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="10013" xml_f="10015" txt_i="4943" txt_f="4945">21</offsets></xref><offsets xml_i="10022" xml_f="10185" txt_i="4945" txt_f="5108">]. These treatments are typically divided into five to ten lesson modules, delivered over several weeks, with some form of therapist support (e.g. email or phone).</offsets></p><p><offsets xml_i="10192" xml_f="10509" txt_i="5109" txt_f="5426">Though iCBT appears promising in treating PTSD, variation in experimental design and course structure means further clinical trials are warranted. Moreover, the role of emotion process variables in PTSD response to iCBT has not been examined. To date, published studies have either not included a control group e.g. [</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="10542" xml_f="10544" txt_i="5426" txt_f="5428">21</offsets></xref><offsets xml_i="10551" xml_f="10588" txt_i="5428" txt_f="5465">], not formally diagnosed PTSD e.g. [</offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="10621" xml_f="10623" txt_i="5465" txt_f="5467">19</offsets></xref><offsets xml_i="10630" xml_f="10683" txt_i="5467" txt_f="5520">], been based on a self-help mode of treatment e.g. [</offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="10716" xml_f="10718" txt_i="5520" txt_f="5522">22</offsets></xref><offsets xml_i="10725" xml_f="10856" txt_i="5522" txt_f="5653">] or required significant initial therapist input to provide psychoeducation and explain treatment components to the patient e.g. [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="10889" xml_f="10891" txt_i="5653" txt_f="5655">18</offsets></xref><offsets xml_i="10898" xml_f="11072" txt_i="5655" txt_f="5829">]. Only two published randomised controlled trials (RCT) to date have examined the efficacy of iCBT for PTSD in a formally diagnosed PTSD sample from the general population [</offsets><xref ref-type="bibr" rid="CR20"><offsets xml_i="11105" xml_f="11107" txt_i="5829" txt_f="5831">20</offsets></xref><offsets xml_i="11114" xml_f="11116" txt_i="5831" txt_f="5833">, </offsets><xref ref-type="bibr" rid="CR23"><offsets xml_i="11149" xml_f="11151" txt_i="5833" txt_f="5835">23</offsets></xref><offsets xml_i="11158" xml_f="11413" txt_i="5835" txt_f="6090">]. However, those studies did not examine mediators of symptom change. Therefore, in order to extend and validate iCBT for PTSD, the proposed study will conduct an RCT to examine the clinical efficacy of this approach and mediators of PTSD symptom change.</offsets></p><p><offsets xml_i="11420" xml_f="11556" txt_i="6091" txt_f="6227">Emerging evidence suggests intolerance of uncertainty (IU) as a transdiagnostic construct central to the expression of psychopathology [</offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="11589" xml_f="11591" txt_i="6227" txt_f="6229">24</offsets></xref><offsets xml_i="11598" xml_f="11599" txt_i="6229" txt_f="6230">–</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="11632" xml_f="11634" txt_i="6230" txt_f="6232">26</offsets></xref><offsets xml_i="11641" xml_f="11792" txt_i="6232" txt_f="6383">]. IU is the tendency to respond to uncertainty with a negative emotional and cognitive set and corresponding avoidance and risk mitigation behaviour [</offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="11825" xml_f="11827" txt_i="6383" txt_f="6385">27</offsets></xref><offsets xml_i="11834" xml_f="11978" txt_i="6385" txt_f="6529">]. Recent research has indicated reduction in IU is associated with anxiety and depressive symptom reduction following psychological treatment [</offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="12011" xml_f="12013" txt_i="6529" txt_f="6531">28</offsets></xref><offsets xml_i="12020" xml_f="12137" txt_i="6531" txt_f="6648">]. With respect to PTSD, IU has been positively associated with severity of arousal, avoidance and numbing symptoms [</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="12170" xml_f="12172" txt_i="6648" txt_f="6650">29</offsets></xref><offsets xml_i="12179" xml_f="12427" txt_i="6650" txt_f="6898">]. However, the association between PTSD treatment and variation in IU has not been investigated, nor has the relationship between change in IU and PTSD symptoms over treatment. Therefore, the current study will examine these relationships in PTSD.</offsets></p><p><offsets xml_i="12434" xml_f="12771" txt_i="6899" txt_f="7236">Finally, recent work has investigated the role of emotion regulation in PTSD treatment outcome. Emotion regulation is the ability to actively influence the timing, experience and expression of emotion. Emotion regulation skills training has been shown to reduce dropout and enhance outcome from subsequent exposure-based PTSD treatment [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="12804" xml_f="12806" txt_i="7236" txt_f="7238">30</offsets></xref><offsets xml_i="12813" xml_f="12815" txt_i="7238" txt_f="7240">, </offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="12848" xml_f="12850" txt_i="7240" txt_f="7242">31</offsets></xref><offsets xml_i="12857" xml_f="12964" txt_i="7242" txt_f="7349">]. Moreover, exposure-based treatment for PTSD has been associated with enhancement in emotion regulation [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="12997" xml_f="12999" txt_i="7349" txt_f="7351">32</offsets></xref><offsets xml_i="13006" xml_f="13149" txt_i="7351" txt_f="7494">]. However, it remains unclear whether emotion regulation before treatment predicts an individual’s response to treatment. While Wisco et al. [</offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="13182" xml_f="13184" txt_i="7494" txt_f="7496">33</offsets></xref><offsets xml_i="13191" xml_f="13782" txt_i="7496" txt_f="8087">] found better pre-treatment emotion regulation skills were not predictive of enhanced PTSD treatment outcome, that treatment omitted in vivo exposure and cognitive restructuring, treatment components to which emotion regulation may be conceptually related. The association between emotion regulation and treatment outcome in an internet-delivered intervention for PTSD comprising written exposure, in vivo exposure and cognitive restructuring has not been investigated. As such, this study seeks to examine the role of emotion regulation in PTSD symptom response to this treatment approach.</offsets></p><sec id="Sec2"><title><offsets xml_i="13808" xml_f="13818" txt_i="8088" txt_f="8098">Objectives</offsets></title><p><offsets xml_i="13829" xml_f="13928" txt_i="8099" txt_f="8198">The current Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-compliant [</offsets><xref ref-type="bibr" rid="CR34"><offsets xml_i="13961" xml_f="13963" txt_i="8198" txt_f="8200">34</offsets></xref><offsets xml_i="13970" xml_f="14030" txt_i="8200" txt_f="8260">] protocol outlines the methodology of a CONSORT-compliant [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="14063" xml_f="14065" txt_i="8260" txt_f="8262">35</offsets></xref><offsets xml_i="14072" xml_f="14390" txt_i="8262" txt_f="8580">] RCT, the primary objective of which is to establish the efficacy of the iCBT program for PTSD. Secondary objectives are to examine change in IU and emotion regulation ability following the iCBT program and the association between change in each of these constructs and PTSD symptom change following the PTSD program.</offsets></p><p><offsets xml_i="14397" xml_f="15228" txt_i="8581" txt_f="9412">The proposed iCBT program aims to reduce psychological distress and PTSD symptoms in those with PTSD. It comprises psychoeducation about the trauma reaction and how it is maintained after the event by particular patterns of thinking, feeling and behaving. Dearousal skills are taught and practiced. Participants are taught ways to identify and change unhelpful thoughts about the trauma. They will be habituated to their challenging trauma memories using a series of brief structured writing assignments and taught graded exposure methods to re-enter feared situations. Finally, relapse prevention will cover continued skills practice and instruction on independent management of potential future setbacks. These elements have been incorporated into standard CBT-based treatment for PTSD both in internet and face-to-face formats [</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="15261" xml_f="15263" txt_i="9412" txt_f="9414">12</offsets></xref><offsets xml_i="15270" xml_f="15272" txt_i="9414" txt_f="9416">, </offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="15305" xml_f="15307" txt_i="9416" txt_f="9418">18</offsets></xref><offsets xml_i="15314" xml_f="15315" txt_i="9418" txt_f="9419">–</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="15348" xml_f="15350" txt_i="9419" txt_f="9421">21</offsets></xref><offsets xml_i="15357" xml_f="15359" txt_i="9421" txt_f="9423">, </offsets><xref ref-type="bibr" rid="CR36"><offsets xml_i="15392" xml_f="15394" txt_i="9423" txt_f="9425">36</offsets></xref><offsets xml_i="15401" xml_f="15402" txt_i="9425" txt_f="9426">–</offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="15435" xml_f="15437" txt_i="9426" txt_f="9428">38</offsets></xref><offsets xml_i="15444" xml_f="15513" txt_i="9428" txt_f="9497">], but have been adapted for the proposed internet treatment program.</offsets></p><p><offsets xml_i="15520" xml_f="16147" txt_i="9498" txt_f="10125">Hypotheses are as follows: (1) patients receiving iCBT for PTSD will show greater mean symptom reduction on a standardised PTSD measure than a waitlist control group during treatment and at the end of treatment (the primary endpoint), with preserved symptom reduction at 3-month follow-up; (2) IU will be less at post-treatment than pre-treatment; (3) reduction in IU over treatment will be associated with reduction in PTSD severity; (4) emotion regulation will be greater at post-treatment than pre-treatment; and (5) increased emotion regulation after treatment will be associated with reduced PTSD severity after treatment.</offsets></p></sec></sec><sec id="Sec3" sec-type="materials|methods"><title><offsets xml_i="16214" xml_f="16228" txt_i="10128" txt_f="10142">Methods/Design</offsets></title><sec id="Sec4"><title><offsets xml_i="16258" xml_f="16271" txt_i="10143" txt_f="10156">Study setting</offsets></title><p><offsets xml_i="16282" xml_f="16690" txt_i="10157" txt_f="10565">The Clinical Research Unit for Anxiety and Depression (CRUfAD) is a non-profit joint initiative of St. Vincent’s Hospital and the University of New South Wales, School of Psychiatry in Sydney, Australia. CRUfAD specialises in the development, evaluation, and dissemination of evidence-based CBT programs via the internet. This RCT will be conducted within the Virtual Clinic, CRUfAD’s clinical research arm (</offsets><ext-link ext-link-type="uri" xlink:href="http://www.virtualclinic.org.au/"><offsets xml_i="16766" xml_f="16790" txt_i="10565" txt_f="10589">www.virtualclinic.org.au</offsets></ext-link><offsets xml_i="16801" xml_f="16952" txt_i="10589" txt_f="10740">). The mode of internet recruitment and delivery enables potential participants from all Australian states to apply for enrolment in the current trial.</offsets></p></sec><sec id="Sec5"><title><offsets xml_i="16984" xml_f="17012" txt_i="10742" txt_f="10770">Participants and recruitment</offsets></title><p><offsets xml_i="17023" xml_f="17219" txt_i="10771" txt_f="10967">Participants will be recruited through flyers, paid print and internet advertising. Applicants will first complete online screening questionnaires about symptoms and demographic details (see Fig. </offsets><xref rid="Fig1" ref-type="fig"><offsets xml_i="17251" xml_f="17252" txt_i="10967" txt_f="10968">1</offsets></xref><offsets xml_i="17259" xml_f="18329" txt_i="10968" txt_f="12038"> for a participant flow chart). Inclusion criteria are as follows: meet diagnostic criteria for PTSD; computer, internet and printer access; Australian resident; fluent in written and spoken English; willing to provide name, phone number and address, and to provide the name and address of a local general practitioner. Exclusion criteria are as follows: trauma occurrence within the past 4 weeks; non-resident of Australia; less than 18 years of age; currently receiving treatment for trauma/PTSD; frequent suicidal ideation (indicated by a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9)); regularly using illicit drugs or regularly consuming more than three standard drinks per day; psychotic disorder or taking atypical antipsychotics or benzodiazepines; if taking medication for anxiety or depression, has been taking the same dose for less than 1 month or intending to change the dose during the course of the program; currently highly dissociative (indicated by score ≥40 on the Dissociative Experiences Scale as per Spence et al. [</offsets><xref ref-type="bibr" rid="CR20"><offsets xml_i="18362" xml_f="18364" txt_i="12038" txt_f="12040">20</offsets></xref><offsets xml_i="18371" xml_f="18867" txt_i="12040" txt_f="12536">]); current or pending medicolegal proceedings associated with the reported trauma; applying for, or receiving, Workers Compensation associated with their trauma or PTSD. Excluded applicants will receive information on alternative services and will be encouraged to discuss their symptoms with their physician. Applicants who pass the screening phase will be telephoned for a diagnostic interview using the PTSD module from the Mini International Neuropsychiatric Interview version 5.0.0 (MINI) [</offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="18900" xml_f="18902" txt_i="12536" txt_f="12538">39</offsets></xref><offsets xml_i="18909" xml_f="19986" txt_i="12538" txt_f="13615">] to determine whether they meet diagnostic criteria for PTSD. All interviews will be conducted by a registered Clinical Psychologist (AA) or Clinical Trials Manager (JS) under the guidance of the Clinical Psychologist and trained in administration of the diagnostic interview. Applicants who satisfy all inclusion criteria will be informed of the study design and will complete an electronic informed consent prior to enrolling in the trial. Information from the diagnostic interview will be used for research purposes only for those participants who provide informed consent. All participants will be informed in writing that they may withdraw from the study (i.e. choose to cease program enrolment or choose for their data to be excluded from the RCT) at any time without jeopardising their relationship with St. Vincent’s Hospital or the University of New South Wales. Further, those participants randomised to the waitlist control group will be informed that should they commence a trauma-focused intervention outside of the trial, their data will be omitted from the RCT.</offsets><fig id="Fig1"><label><offsets xml_i="20008" xml_f="20014" txt_i="13615" txt_f="13621">Fig. 1</offsets></label><caption><p><offsets xml_i="20034" xml_f="20056" txt_i="13621" txt_f="13643">Participant flow chart</offsets></p></caption><graphic xlink:href="13063_2015_1059_Fig1_HTML" id="MO1"></graphic></fig></p></sec><sec id="Sec6"><title><offsets xml_i="20175" xml_f="20200" txt_i="13646" txt_f="13671">Trial design and blinding</offsets></title><p><offsets xml_i="20211" xml_f="20495" txt_i="13672" txt_f="13956">The trial is a randomised controlled superiority trial with two parallel arms using a 1:1 allocation ratio. Participants will not be blind to their group allocation. Follow-up interviews will be conducted by clinicians independent of the study and therefore blind to group allocation.</offsets></p></sec><sec id="Sec7"><title><offsets xml_i="20527" xml_f="20540" txt_i="13958" txt_f="13971">Randomisation</offsets></title><p><offsets xml_i="20551" xml_f="20719" txt_i="13972" txt_f="14140">Accepted participants will be randomised based on an allocation sequence generated by an independent person not involved in the study via a true randomisation process (</offsets><ext-link ext-link-type="uri" xlink:href="http://www.random.org/"><offsets xml_i="20785" xml_f="20799" txt_i="14140" txt_f="14154">www.random.org</offsets></ext-link><offsets xml_i="20810" xml_f="21139" txt_i="14154" txt_f="14483">). Numbers corresponding to treatment group (1) or the waitlist control group (2) will be placed in sealed opaque envelopes bearing the sequential order number to ensure participant allocation based on the pre-determined randomisation sequence. A member of the research team will open the envelope after the diagnostic interview.</offsets></p></sec><sec id="Sec8"><title><offsets xml_i="21171" xml_f="21195" txt_i="14485" txt_f="14509">Primary outcome measures</offsets></title><p><offsets xml_i="21206" xml_f="21276" txt_i="14510" txt_f="14580">Administration time points for all instruments are contained in Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="21310" xml_f="21311" txt_i="14580" txt_f="14581">1</offsets></xref><offsets xml_i="21318" xml_f="21319" txt_i="14581" txt_f="14582">.</offsets><table-wrap id="Tab1"><label><offsets xml_i="21348" xml_f="21355" txt_i="14582" txt_f="14589">Table 1</offsets></label><caption><p><offsets xml_i="21375" xml_f="21436" txt_i="14589" txt_f="14650">Administration time points for questionnaires used in the RCT</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th colspan="5"><offsets xml_i="21523" xml_f="21548" txt_i="14651" txt_f="14676">Administration time point</offsets></th></tr><tr><th><offsets xml_i="21566" xml_f="21573" txt_i="14676" txt_f="14683">Measure</offsets></th><th><offsets xml_i="21582" xml_f="21595" txt_i="14683" txt_f="14696">Pre-treatment</offsets></th><th><offsets xml_i="21604" xml_f="21622" txt_i="14696" txt_f="14714">Before each lesson</offsets></th><th><offsets xml_i="21631" xml_f="21645" txt_i="14714" txt_f="14728">Mid -treatment</offsets><sup><offsets xml_i="21650" xml_f="21651" txt_i="14728" txt_f="14729">d</offsets></sup><offsets xml_i="21657" xml_f="21658" txt_i="14729" txt_f="14730">
</offsets></th><th><offsets xml_i="21667" xml_f="21681" txt_i="14730" txt_f="14744">Post-treatment</offsets><sup><offsets xml_i="21686" xml_f="21687" txt_i="14744" txt_f="14745">e</offsets></sup><offsets xml_i="21693" xml_f="21694" txt_i="14745" txt_f="14746">
</offsets></th><th><offsets xml_i="21703" xml_f="21720" txt_i="14746" txt_f="14763">3-month follow-up</offsets><sup><offsets xml_i="21725" xml_f="21726" txt_i="14763" txt_f="14764">f</offsets></sup><offsets xml_i="21732" xml_f="21733" txt_i="14764" txt_f="14765">
</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="21766" xml_f="21769" txt_i="14765" txt_f="14768">LEC</offsets><sup><offsets xml_i="21774" xml_f="21775" txt_i="14768" txt_f="14769">a</offsets></sup><offsets xml_i="21781" xml_f="21782" txt_i="14769" txt_f="14770">
</offsets></td><td><offsets xml_i="21791" xml_f="21792" txt_i="14771" txt_f="14772">♦</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="21846" xml_f="21849" txt_i="14777" txt_f="14780">DES</offsets></td><td><offsets xml_i="21858" xml_f="21859" txt_i="14781" txt_f="14782">♦</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="21913" xml_f="21917" txt_i="14787" txt_f="14791">MINI</offsets></td><td><offsets xml_i="21926" xml_f="21927" txt_i="14792" txt_f="14793">♦</offsets></td><td></td><td></td><td></td><td><offsets xml_i="21963" xml_f="21964" txt_i="14797" txt_f="14798">♦</offsets></td></tr><tr><td><offsets xml_i="21982" xml_f="21987" txt_i="14799" txt_f="14804">PCL-C</offsets><sup><offsets xml_i="21992" xml_f="21993" txt_i="14804" txt_f="14805">b</offsets></sup><offsets xml_i="21999" xml_f="22000" txt_i="14805" txt_f="14806">
</offsets></td><td><offsets xml_i="22009" xml_f="22010" txt_i="14807" txt_f="14808">♦</offsets></td><td><offsets xml_i="22019" xml_f="22020" txt_i="14809" txt_f="14810">♦</offsets></td><td><offsets xml_i="22029" xml_f="22030" txt_i="14811" txt_f="14812">♦</offsets></td><td><offsets xml_i="22039" xml_f="22040" txt_i="14813" txt_f="14814">♦</offsets></td><td><offsets xml_i="22049" xml_f="22050" txt_i="14815" txt_f="14816">♦</offsets></td></tr><tr><td><offsets xml_i="22068" xml_f="22074" txt_i="14817" txt_f="14823">BDI-II</offsets><sup><offsets xml_i="22079" xml_f="22080" txt_i="14823" txt_f="14824">c</offsets></sup><offsets xml_i="22086" xml_f="22087" txt_i="14824" txt_f="14825">
</offsets></td><td><offsets xml_i="22096" xml_f="22097" txt_i="14826" txt_f="14827">♦</offsets></td><td></td><td><offsets xml_i="22115" xml_f="22116" txt_i="14829" txt_f="14830">♦</offsets></td><td><offsets xml_i="22125" xml_f="22126" txt_i="14831" txt_f="14832">♦</offsets></td><td><offsets xml_i="22135" xml_f="22136" txt_i="14833" txt_f="14834">♦</offsets></td></tr><tr><td><offsets xml_i="22154" xml_f="22159" txt_i="14835" txt_f="14840">PHQ-9</offsets></td><td><offsets xml_i="22168" xml_f="22169" txt_i="14841" txt_f="14842">♦</offsets></td><td></td><td><offsets xml_i="22187" xml_f="22188" txt_i="14844" txt_f="14845">♦</offsets></td><td><offsets xml_i="22197" xml_f="22198" txt_i="14846" txt_f="14847">♦</offsets></td><td><offsets xml_i="22207" xml_f="22208" txt_i="14848" txt_f="14849">♦</offsets></td></tr><tr><td><offsets xml_i="22226" xml_f="22229" txt_i="14850" txt_f="14853">K10</offsets></td><td><offsets xml_i="22238" xml_f="22239" txt_i="14854" txt_f="14855">♦</offsets></td><td><offsets xml_i="22248" xml_f="22249" txt_i="14856" txt_f="14857">♦</offsets></td><td><offsets xml_i="22258" xml_f="22259" txt_i="14858" txt_f="14859">♦</offsets></td><td><offsets xml_i="22268" xml_f="22269" txt_i="14860" txt_f="14861">♦</offsets></td><td><offsets xml_i="22278" xml_f="22279" txt_i="14862" txt_f="14863">♦</offsets></td></tr><tr><td><offsets xml_i="22297" xml_f="22302" txt_i="14864" txt_f="14869">GAD-7</offsets></td><td><offsets xml_i="22311" xml_f="22312" txt_i="14870" txt_f="14871">♦</offsets></td><td></td><td><offsets xml_i="22330" xml_f="22331" txt_i="14873" txt_f="14874">♦</offsets></td><td><offsets xml_i="22340" xml_f="22341" txt_i="14875" txt_f="14876">♦</offsets></td><td><offsets xml_i="22350" xml_f="22351" txt_i="14877" txt_f="14878">♦</offsets></td></tr><tr><td><offsets xml_i="22369" xml_f="22372" txt_i="14879" txt_f="14882">CEQ</offsets></td><td><offsets xml_i="22381" xml_f="22382" txt_i="14883" txt_f="14884">♦</offsets></td><td></td><td></td><td><offsets xml_i="22409" xml_f="22410" txt_i="14887" txt_f="14888">♦</offsets></td><td></td></tr><tr><td><offsets xml_i="22437" xml_f="22443" txt_i="14890" txt_f="14896">IUS-12</offsets></td><td><offsets xml_i="22452" xml_f="22453" txt_i="14897" txt_f="14898">♦</offsets></td><td></td><td><offsets xml_i="22471" xml_f="22472" txt_i="14900" txt_f="14901">♦</offsets></td><td><offsets xml_i="22481" xml_f="22482" txt_i="14902" txt_f="14903">♦</offsets></td><td><offsets xml_i="22491" xml_f="22492" txt_i="14904" txt_f="14905">♦</offsets></td></tr><tr><td><offsets xml_i="22510" xml_f="22513" txt_i="14906" txt_f="14909">ERQ</offsets></td><td><offsets xml_i="22522" xml_f="22523" txt_i="14910" txt_f="14911">♦</offsets></td><td></td><td><offsets xml_i="22541" xml_f="22542" txt_i="14913" txt_f="14914">♦</offsets></td><td><offsets xml_i="22551" xml_f="22552" txt_i="14915" txt_f="14916">♦</offsets></td><td><offsets xml_i="22561" xml_f="22562" txt_i="14917" txt_f="14918">♦</offsets></td></tr><tr><td><offsets xml_i="22580" xml_f="22585" txt_i="14919" txt_f="14924">SUDOR</offsets></td><td><offsets xml_i="22594" xml_f="22595" txt_i="14925" txt_f="14926">♦</offsets></td><td></td><td><offsets xml_i="22613" xml_f="22614" txt_i="14928" txt_f="14929">♦</offsets></td><td><offsets xml_i="22623" xml_f="22624" txt_i="14930" txt_f="14931">♦</offsets></td><td><offsets xml_i="22633" xml_f="22634" txt_i="14932" txt_f="14933">♦</offsets></td></tr><tr><td><offsets xml_i="22652" xml_f="22657" txt_i="14934" txt_f="14939">SAPAS</offsets></td><td><offsets xml_i="22666" xml_f="22667" txt_i="14940" txt_f="14941">♦</offsets></td><td></td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="22749" xml_f="22750" txt_i="14946" txt_f="14947">
</offsets><italic><offsets xml_i="22758" xml_f="22761" txt_i="14947" txt_f="14950">LEC</offsets></italic><offsets xml_i="22770" xml_f="22794" txt_i="14950" txt_f="14974"> Life Events Checklist, </offsets><italic><offsets xml_i="22802" xml_f="22805" txt_i="14974" txt_f="14977">DES</offsets></italic><offsets xml_i="22814" xml_f="22847" txt_i="14977" txt_f="15010"> Dissociative Experiences Scale, </offsets><italic><offsets xml_i="22855" xml_f="22859" txt_i="15010" txt_f="15014">MINI</offsets></italic><offsets xml_i="22868" xml_f="22911" txt_i="15014" txt_f="15057"> Mini International Psychiatric Interview, </offsets><italic><offsets xml_i="22919" xml_f="22924" txt_i="15057" txt_f="15062">PCL-C</offsets></italic><offsets xml_i="22933" xml_f="22949" txt_i="15062" txt_f="15078"> PTSD Checklist </offsets><bold><offsets xml_i="22955" xml_f="22956" txt_i="15078" txt_f="15079">–</offsets></bold><offsets xml_i="22963" xml_f="22982" txt_i="15079" txt_f="15098"> Civilian version, </offsets><italic><offsets xml_i="22990" xml_f="22996" txt_i="15098" txt_f="15104">BDI-II</offsets></italic><offsets xml_i="23005" xml_f="23050" txt_i="15104" txt_f="15149"> Beck Depression Inventory – Second Edition, </offsets><italic><offsets xml_i="23058" xml_f="23063" txt_i="15149" txt_f="15154">PHQ-9</offsets></italic><offsets xml_i="23072" xml_f="23118" txt_i="15154" txt_f="15200"> Patient Health Questionnaire 9-item version, </offsets><italic><offsets xml_i="23126" xml_f="23129" txt_i="15200" txt_f="15203">K10</offsets></italic><offsets xml_i="23138" xml_f="23193" txt_i="15203" txt_f="15258"> Kessler Psychological Distress Scale 10-item version, </offsets><italic><offsets xml_i="23201" xml_f="23206" txt_i="15258" txt_f="15263">GAD-7</offsets></italic><offsets xml_i="23215" xml_f="23259" txt_i="15263" txt_f="15307"> Generalised Anxiety Disorder 7-Item Scale, </offsets><italic><offsets xml_i="23267" xml_f="23270" txt_i="15307" txt_f="15310">CEQ</offsets></italic><offsets xml_i="23279" xml_f="23337" txt_i="15310" txt_f="15368"> - Credibility and Expectancy/Satisfaction Questionnaire, </offsets><italic><offsets xml_i="23345" xml_f="23351" txt_i="15368" txt_f="15374">IUS-12</offsets></italic><offsets xml_i="23360" xml_f="23411" txt_i="15374" txt_f="15425"> Intolerance of Uncertainty Scale 12-item version, </offsets><italic><offsets xml_i="23419" xml_f="23422" txt_i="15425" txt_f="15428">ERQ</offsets></italic><offsets xml_i="23431" xml_f="23466" txt_i="15428" txt_f="15463"> Emotion Regulation Questionnaire, </offsets><italic><offsets xml_i="23474" xml_f="23479" txt_i="15463" txt_f="15468">SUDOR</offsets></italic><offsets xml_i="23488" xml_f="23545" txt_i="15468" txt_f="15525"> Service Utilisation and Days Out of Role Questionnaire, </offsets><italic><offsets xml_i="23553" xml_f="23558" txt_i="15525" txt_f="15530">SAPAS</offsets></italic><offsets xml_i="23567" xml_f="23626" txt_i="15530" txt_f="15589"> Standardised Assessment of Personality - Abbreviated Scale</offsets></p><p><offsets xml_i="23633" xml_f="23634" txt_i="15590" txt_f="15591">
</offsets><sup><offsets xml_i="23639" xml_f="23640" txt_i="15591" txt_f="15592">a</offsets></sup><offsets xml_i="23646" xml_f="23687" txt_i="15592" txt_f="15633">Refers to both LEC-IV and part 2 of LEC-5</offsets></p><p><offsets xml_i="23694" xml_f="23695" txt_i="15634" txt_f="15635">
</offsets><sup><offsets xml_i="23700" xml_f="23701" txt_i="15635" txt_f="15636">b</offsets></sup><offsets xml_i="23707" xml_f="23747" txt_i="15636" txt_f="15676">Includes items 10, 11, and 16 from PCL-5</offsets></p><p><offsets xml_i="23754" xml_f="23755" txt_i="15677" txt_f="15678">
</offsets><sup><offsets xml_i="23760" xml_f="23761" txt_i="15678" txt_f="15679">c</offsets></sup><offsets xml_i="23767" xml_f="23778" txt_i="15679" txt_f="15690">Item 9 only</offsets></p><p><offsets xml_i="23785" xml_f="23786" txt_i="15691" txt_f="15692">
</offsets><sup><offsets xml_i="23791" xml_f="23792" txt_i="15692" txt_f="15693">d</offsets></sup><offsets xml_i="23798" xml_f="23878" txt_i="15693" txt_f="15773">Waitlist control group completes these measures at week 5 of the waitlist period</offsets></p><p><offsets xml_i="23885" xml_f="23886" txt_i="15774" txt_f="15775">
</offsets><sup><offsets xml_i="23891" xml_f="23892" txt_i="15775" txt_f="15776">e</offsets></sup><offsets xml_i="23898" xml_f="23979" txt_i="15776" txt_f="15857">Waitlist control group completes these measures at week 11 of the waitlist period</offsets></p><p><offsets xml_i="23986" xml_f="23987" txt_i="15858" txt_f="15859">
</offsets><sup><offsets xml_i="23992" xml_f="23993" txt_i="15859" txt_f="15860">f</offsets></sup><offsets xml_i="23999" xml_f="24019" txt_i="15860" txt_f="15880">Treatment group only</offsets></p></table-wrap-foot></table-wrap></p><p><bold><offsets xml_i="24067" xml_f="24125" txt_i="15882" txt_f="15940">Posttraumatic stress disorder Checklist – Civilian version</offsets></bold><offsets xml_i="24132" xml_f="24142" txt_i="15940" txt_f="15950"> (PCL-C) [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="24175" xml_f="24177" txt_i="15950" txt_f="15952">40</offsets></xref><offsets xml_i="24184" xml_f="24557" txt_i="15952" txt_f="16325">]. The PCL-C is a 17-item self-report questionnaire providing a continuous measure of PTSD symptomatology, conforming to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnostic criteria. Each item reflects a PTSD symptom and is rated on a 5-point scale for distress (1 = “Not at all”; 5 = “Extremely”). Items 10, 11 and 16 from the PCL-5 [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="24590" xml_f="24592" txt_i="16325" txt_f="16327">41</offsets></xref><offsets xml_i="24599" xml_f="24910" txt_i="16327" txt_f="16638">] will also be administered, which assess new diagnostic criteria for PTSD in the fifth edition of the DSM [DSM-5 1]. This approach was adopted in favour of sole use of the PCL-5, which had not been validated at the time of trial design. This will enable examination of change in the new PTSD symptoms in DSM-5.</offsets></p><p><bold><offsets xml_i="24923" xml_f="24945" txt_i="16639" txt_f="16661">PTSD diagnostic status</offsets></bold><offsets xml_i="24952" xml_f="25090" txt_i="16661" txt_f="16799">. Change in PTSD diagnostic status will be indexed using the MINI PTSD module. The MINI has sound reliability and validity psychometrics [</offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="25123" xml_f="25125" txt_i="16799" txt_f="16801">39</offsets></xref><offsets xml_i="25132" xml_f="25134" txt_i="16801" txt_f="16803">].</offsets></p></sec><sec id="Sec9"><title><offsets xml_i="25166" xml_f="25192" txt_i="16805" txt_f="16831">Secondary outcome measures</offsets></title><p><bold><offsets xml_i="25209" xml_f="25250" txt_i="16832" txt_f="16873">Patient Health Questionnaire 9-item scale</offsets></bold><offsets xml_i="25257" xml_f="25267" txt_i="16873" txt_f="16883"> (PHQ-9) [</offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="25300" xml_f="25302" txt_i="16883" txt_f="16885">42</offsets></xref><offsets xml_i="25309" xml_f="25791" txt_i="16885" txt_f="17367">]. The PHQ-9 is a self-report questionnaire corresponding to DSM-IV diagnostic criteria for major depressive disorder. Each item is rated in frequency on a 4-point scale (0 = “Not at all”; 3 = “Nearly every day”). Total scores range from 0 to 27 with higher scores reflecting greater symptom severity. The PHQ9 demonstrates sound psychometric properties and has been used extensively to measure treatment outcomes during internet CBT interventions targeting depression and anxiety [</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="25824" xml_f="25826" txt_i="17367" txt_f="17369">43</offsets></xref><offsets xml_i="25833" xml_f="25835" txt_i="17369" txt_f="17371">, </offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="25868" xml_f="25870" txt_i="17371" txt_f="17373">44</offsets></xref><offsets xml_i="25877" xml_f="25879" txt_i="17373" txt_f="17375">].</offsets></p><p><bold><offsets xml_i="25892" xml_f="25931" txt_i="17376" txt_f="17415">Kessler-10 Psychological Distress Scale</offsets></bold><offsets xml_i="25938" xml_f="25946" txt_i="17415" txt_f="17423"> (K10) [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="25979" xml_f="25981" txt_i="17423" txt_f="17425">45</offsets></xref><offsets xml_i="25988" xml_f="26290" txt_i="17425" txt_f="17727">]. The K10 consists of 10 items ranked on a 5-point scale designed to measure non-specific psychological distress. For the current study, the time frame was modified to assess psychological distress in the past 2 weeks rather than in the past 30 days. The K10 possesses strong psychometric properties [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="26323" xml_f="26325" txt_i="17727" txt_f="17729">45</offsets></xref><offsets xml_i="26332" xml_f="26334" txt_i="17729" txt_f="17731">, </offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="26367" xml_f="26369" txt_i="17731" txt_f="17733">46</offsets></xref><offsets xml_i="26376" xml_f="26378" txt_i="17733" txt_f="17735">].</offsets></p><p><bold><offsets xml_i="26391" xml_f="26432" txt_i="17736" txt_f="17777">Generalised Anxiety Disorder 7-Item Scale</offsets></bold><offsets xml_i="26439" xml_f="26449" txt_i="17777" txt_f="17787"> (GAD-7) [</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="26482" xml_f="26484" txt_i="17787" txt_f="17789">47</offsets></xref><offsets xml_i="26491" xml_f="26802" txt_i="17789" txt_f="18100">]. The GAD-7 is composed of seven items examining GAD symptom severity and is based on DSM-IV criteria. Items are measured on a 4-point scale for frequency of interference from symptoms over the past 2 weeks (0 = “Not at all”; 3 = “Nearly every day”). Internal consistency and test-retest reliability are high [</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="26835" xml_f="26837" txt_i="18100" txt_f="18102">47</offsets></xref><offsets xml_i="26844" xml_f="26846" txt_i="18102" txt_f="18104">, </offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="26879" xml_f="26881" txt_i="18104" txt_f="18106">48</offsets></xref><offsets xml_i="26888" xml_f="26890" txt_i="18106" txt_f="18108">].</offsets></p><p><bold><offsets xml_i="26903" xml_f="26948" txt_i="18109" txt_f="18154">Intolerance of Uncertainty Scale – Short Form</offsets></bold><offsets xml_i="26955" xml_f="26966" txt_i="18154" txt_f="18165"> (IUS-12) [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="26999" xml_f="27001" txt_i="18165" txt_f="18167">49</offsets></xref><offsets xml_i="27008" xml_f="27099" txt_i="18167" txt_f="18258">]. The IUS-12 is a psychometrically reliable, valid measure of intolerance of uncertainty [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="27132" xml_f="27134" txt_i="18258" txt_f="18260">49</offsets></xref><offsets xml_i="27141" xml_f="27281" txt_i="18260" txt_f="18400">]. It contains 12 items, each measured on a 5-point scale from 1 (“Not at all characteristic of me”) to 5 (“Entirely characteristic of me”).</offsets></p><p><bold><offsets xml_i="27294" xml_f="27326" txt_i="18401" txt_f="18433">Emotion Regulation Questionnaire</offsets></bold><offsets xml_i="27333" xml_f="27341" txt_i="18433" txt_f="18441"> (ERQ) [</offsets><xref ref-type="bibr" rid="CR50"><offsets xml_i="27374" xml_f="27376" txt_i="18441" txt_f="18443">50</offsets></xref><offsets xml_i="27383" xml_f="27713" txt_i="18443" txt_f="18773">]. The ERQ is a 10-item self-report measure of cognitive reappraisal and emotional suppression as means of regulating emotion. Items are scored on a 7-point scale to represent their use by the individual from 1 (“Strongly disagree”) to 7 (“Strongly agree”). This measure has sound reliability (including test-retest reliability) [</offsets><xref ref-type="bibr" rid="CR51"><offsets xml_i="27746" xml_f="27748" txt_i="18773" txt_f="18775">51</offsets></xref><offsets xml_i="27755" xml_f="27757" txt_i="18775" txt_f="18777">].</offsets></p><p><bold><offsets xml_i="27770" xml_f="27827" txt_i="18778" txt_f="18835">Service Use and Days Out of Role Questionnaire - modified</offsets></bold><offsets xml_i="27834" xml_f="27844" txt_i="18835" txt_f="18845"> (SUDOR) [</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="27877" xml_f="27879" txt_i="18845" txt_f="18847">52</offsets></xref><offsets xml_i="27886" xml_f="28294" txt_i="18847" txt_f="19255">]. The SUDOR contains three items that measure the impact of symptoms on daily functioning including doctor (or other health professional) visits and days out of role or reduced functioning due to symptom impact. Items are presented in the form of open questions. Four additional items were included enquiring as to medication use and additional current treatment or activities undertaken to manage symptoms.</offsets></p><p><bold><offsets xml_i="28307" xml_f="28360" txt_i="19256" txt_f="19309">Credibility and Expectancy/Satisfaction Questionnaire</offsets></bold><offsets xml_i="28367" xml_f="28388" txt_i="19309" txt_f="19330"> (CEQ) adapted from [</offsets><xref ref-type="bibr" rid="CR53"><offsets xml_i="28421" xml_f="28423" txt_i="19330" txt_f="19332">53</offsets></xref><offsets xml_i="28430" xml_f="29311" txt_i="19332" txt_f="20213">]. At baseline, participants will complete two treatment expectancy questions: (1) “At this point, how logical does the program offered to you seem?” (0 = “Not at all logical”; 9 = “Very logical”) and (2) “At this point, how successfully do you think this treatment will be in reducing your PTSD symptoms?” (0 = “Not at all useful”; 4 = “Very useful”). Following the combined intervention, participants will also rate treatment satisfaction: “How satisfied are you with the skills that this program has taught you to manage your PTSD?” (1 = “Not at all satisfied”; 9 = “Very satisfied”); “How confident would you be in recommending this treatment to a friend who experiences similar problems?” (1 = “Not at all confident”; 9 = “Very confident”); followed by two questions about difficulty with the program and requesting additional feedback, which will require free text responses.</offsets></p></sec><sec id="Sec10"><title><offsets xml_i="29344" xml_f="29363" txt_i="20215" txt_f="20234">Additional measures</offsets></title><p><bold><offsets xml_i="29380" xml_f="29412" txt_i="20235" txt_f="20267">Life Events Checklist for DSM-IV</offsets></bold><offsets xml_i="29419" xml_f="29430" txt_i="20267" txt_f="20278"> (LEC-IV) [</offsets><xref ref-type="bibr" rid="CR54"><offsets xml_i="29463" xml_f="29465" txt_i="20278" txt_f="20280">54</offsets></xref><offsets xml_i="29472" xml_f="29931" txt_i="20280" txt_f="20739">]. The LEC-IV will be used to screen for exposure to traumatic life events. The LEC-IV assesses exposure to 16 potentially traumatic events (PTEs) plus one “other” item to capture PTEs not included in other items. It requires respondents to code how each event was experienced (i.e. “It happened to me; I witnessed it; I learned about it; Not sure; Doesn’t apply to me”). It has sound test-retest reliability and convergent validity with comparable measures [</offsets><xref ref-type="bibr" rid="CR55"><offsets xml_i="29964" xml_f="29966" txt_i="20739" txt_f="20741">55</offsets></xref><offsets xml_i="29973" xml_f="29975" txt_i="20741" txt_f="20743">].</offsets></p><p><bold><offsets xml_i="29988" xml_f="30033" txt_i="20744" txt_f="20789">Part 2 of the Life Events Checklist for DSM-5</offsets></bold><offsets xml_i="30040" xml_f="30050" txt_i="20789" txt_f="20799"> (LEC-5) [</offsets><xref ref-type="bibr" rid="CR56"><offsets xml_i="30083" xml_f="30085" txt_i="20799" txt_f="20801">56</offsets></xref><offsets xml_i="30092" xml_f="30297" txt_i="20801" txt_f="21006">]. The LEC-5 will be used to obtain additional information about reported traumatic life events not obtained from LEC-IV, including brief description of event, time since trauma, traumatic event frequency.</offsets></p><p><bold><offsets xml_i="30310" xml_f="30365" txt_i="21007" txt_f="21062">Beck Depression Inventory – Second Edition – Question 9</offsets></bold><offsets xml_i="30372" xml_f="30383" txt_i="21062" txt_f="21073"> (BDI-II) [</offsets><xref ref-type="bibr" rid="CR57"><offsets xml_i="30416" xml_f="30418" txt_i="21073" txt_f="21075">57</offsets></xref><offsets xml_i="30425" xml_f="30661" txt_i="21075" txt_f="21311">]. The BDI-II is a 21-item self-report inventory that measures depressive symptoms. The BDI-II possesses high internal consistency, with alpha coefficients of 0.86 and 0.81 for psychiatric and non-psychiatric populations, respectively [</offsets><xref ref-type="bibr" rid="CR57"><offsets xml_i="30694" xml_f="30696" txt_i="21311" txt_f="21313">57</offsets></xref><offsets xml_i="30703" xml_f="30990" txt_i="21313" txt_f="21600">]. Only Question 9 from this questionnaire will be used to help determine suicidal ideation and suicide risk. Patients indicate their level of intent to commit suicide, on a 4-point scale (0 = “I don’t have any thoughts of killing myself”; 3 = “I would kill myself if I had the chance”).</offsets></p><p><bold><offsets xml_i="31003" xml_f="31033" txt_i="21601" txt_f="21631">Dissociative Experiences Scale</offsets></bold><offsets xml_i="31040" xml_f="31048" txt_i="21631" txt_f="21639"> (DES) [</offsets><xref ref-type="bibr" rid="CR58"><offsets xml_i="31081" xml_f="31083" txt_i="21639" txt_f="21641">58</offsets></xref><offsets xml_i="31090" xml_f="31372" txt_i="21641" txt_f="21923">]. This is a 28-item measure of dissociative symptoms. Respondents indicate the frequency of dissociative experiences on an 11-point scale, increasing in 10-point increments from 0 % (never) to 100 % (always). This measure has strong internal consistency and reliability over time [</offsets><xref ref-type="bibr" rid="CR59"></xref><offsets xml_i="31412" xml_f="31414" txt_i="21923" txt_f="21925">].</offsets></p><p><bold><offsets xml_i="31427" xml_f="31487" txt_i="21926" txt_f="21986">Skills of Cognitive Behaviour Therapy for PTSD Questionnaire</offsets></bold><offsets xml_i="31494" xml_f="31582" txt_i="21986" txt_f="22074">. This measure has been adapted from the Skills of Cognitive Therapy – Patient version [</offsets><xref ref-type="bibr" rid="CR60"><offsets xml_i="31615" xml_f="31617" txt_i="22074" txt_f="22076">60</offsets></xref><offsets xml_i="31624" xml_f="31968" txt_i="22076" txt_f="22420">]. It is a 20-item self-report measure designed to assess patients' understanding and use of basic CBT skills in the PTSD program. Ratings of patients' skill usage are made on a 5-point scale (1 = “Never”; to 5 = “Always or when needed”). Higher scores reflect greater patient subjective skill in applying CBT therapy principles for their PTSD.</offsets></p><p><bold><offsets xml_i="31981" xml_f="32014" txt_i="22421" txt_f="22454">Likely Comorbid Diagnostic Status</offsets></bold><offsets xml_i="32021" xml_f="32262" txt_i="22454" txt_f="22695">. Likely comorbid generalised anxiety disorder (GAD), social phobia (SP), panic disorder, agoraphobia and obsessive compulsive disorder (OCD) status will be indexed by asking the initial enquiry question from the relevant module in the MINI.</offsets></p><p><bold><offsets xml_i="32275" xml_f="32313" txt_i="22696" txt_f="22734">Standardised Assessment of Personality</offsets></bold><offsets xml_i="32320" xml_f="32323" txt_i="22734" txt_f="22737"> – </offsets><bold><offsets xml_i="32329" xml_f="32346" txt_i="22737" txt_f="22754">Abbreviated Scale</offsets></bold><offsets xml_i="32353" xml_f="32363" txt_i="22754" txt_f="22764"> (SAPAS) [</offsets><xref ref-type="bibr" rid="CR61"><offsets xml_i="32396" xml_f="32398" txt_i="22764" txt_f="22766">61</offsets></xref><offsets xml_i="32405" xml_f="32583" txt_i="22766" txt_f="22944">]. The SAPAS is an 8-item screen for DSM-IV personality disorder, with each item requiring a Yes/No response. It is a sensitive, specific measure of likely personality disorder [</offsets><xref ref-type="bibr" rid="CR61"><offsets xml_i="32616" xml_f="32618" txt_i="22944" txt_f="22946">61</offsets></xref><offsets xml_i="32625" xml_f="32627" txt_i="22946" txt_f="22948">].</offsets></p></sec><sec id="Sec11"><title><offsets xml_i="32660" xml_f="32673" txt_i="22950" txt_f="22963">Interventions</offsets></title><sec id="Sec12"><title><offsets xml_i="32704" xml_f="32727" txt_i="22964" txt_f="22987">ICBT – the PTSD program</offsets></title><p><offsets xml_i="32738" xml_f="33138" txt_i="22988" txt_f="23388">The PTSD program consists of six online lessons in the form of a cartoon narrative that contains best practice CBT as well as regular homework assignments and access to supplementary resources. Lesson summaries and skills practice homework assignments are available for download by participants following each lesson. Homework tasks encourage practice of the skills covered in each lesson (see Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="33172" xml_f="33173" txt_i="23388" txt_f="23389">2</offsets></xref><offsets xml_i="33180" xml_f="33840" txt_i="23389" txt_f="24049">). The program is completed over 10 weeks. Participants will be encouraged to complete the program within this time and receive automated reminders to progress. There will be a 5-day minimum interval from completing one lesson before the next is accessible to encourage skills practice before continuing. However, participants can choose to log in at any time beyond this. Participants can also choose the duration they spend on each lesson and skills practice. Participants are encouraged to spend 3–4 hours per week on lesson content and associated skills practice. An outline of key skills and resources covered across the PTSD program is provided in Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="33874" xml_f="33875" txt_i="24049" txt_f="24050">2</offsets></xref><offsets xml_i="33882" xml_f="34160" txt_i="24050" txt_f="24328">. Lessons are followed by skills practice assignments completed independently by patients throughout the iCBT program. This model has strong empirical support for the effective treatment of depression, GAD, SP, PD with and without agoraphobia, and mixed anxiety and depression [</offsets><xref ref-type="bibr" rid="CR62"><offsets xml_i="34193" xml_f="34195" txt_i="24328" txt_f="24330">62</offsets></xref><offsets xml_i="34202" xml_f="34465" txt_i="24330" txt_f="24593">], and is already used by our online treatment service, THIS WAY UP Clinic at St Vincent’s Hospital Sydney, Australia. Courses for the treatment of these other disorders are currently available to patients and, to date, over 5000 patients have completed a course.</offsets><table-wrap id="Tab2"><label><offsets xml_i="34494" xml_f="34501" txt_i="24593" txt_f="24600">Table 2</offsets></label><caption><p><offsets xml_i="34521" xml_f="34624" txt_i="24600" txt_f="24703">Skills and additional resources covered over the posttraumatic stress disorder (PTSD) program by lesson</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="34690" xml_f="34696" txt_i="24704" txt_f="24710">Lesson</offsets></th><th><offsets xml_i="34705" xml_f="34711" txt_i="24710" txt_f="24716">Skills</offsets></th><th><offsets xml_i="34720" xml_f="34735" txt_i="24716" txt_f="24731">Extra resources</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="34768" xml_f="34769" txt_i="24731" txt_f="24732">1</offsets></td><td><offsets xml_i="34778" xml_f="34827" txt_i="24733" txt_f="24782">• Psychoeducation on PTSD diagnosis and treatment</offsets></td><td><offsets xml_i="34836" xml_f="34851" txt_i="24783" txt_f="24798">• Managing mood</offsets><break></break><offsets xml_i="34866" xml_f="34873" txt_i="24798" txt_f="24805">• Sleep</offsets><break></break><offsets xml_i="34888" xml_f="34924" txt_i="24805" txt_f="24841">• Information for family and friends</offsets></td></tr><tr><td><offsets xml_i="34942" xml_f="34943" txt_i="24842" txt_f="24843">2</offsets></td><td><offsets xml_i="34952" xml_f="34970" txt_i="24844" txt_f="24862">• Psychoeducation:</offsets><break></break><offsets xml_i="34985" xml_f="35017" txt_i="24862" txt_f="24894">
 o How avoidance maintains PTSD</offsets><break></break><offsets xml_i="35032" xml_f="35060" txt_i="24894" txt_f="24922">
 o Fight-or-flight response</offsets><break></break><offsets xml_i="35075" xml_f="35114" txt_i="24922" txt_f="24961">
 o Cognitive behavioural model of PTSD</offsets><break></break><offsets xml_i="35129" xml_f="35174" txt_i="24961" txt_f="25006">
 o About cognitive behavioural therapy (CBT)</offsets><break></break><offsets xml_i="35189" xml_f="35211" txt_i="25006" txt_f="25028">• Controlled breathing</offsets></td><td><offsets xml_i="35220" xml_f="35251" txt_i="25029" txt_f="25060">• Progressive muscle relaxation</offsets><break></break><offsets xml_i="35266" xml_f="35294" txt_i="25060" txt_f="25088">• Structured problem solving</offsets></td></tr><tr><td><offsets xml_i="35312" xml_f="35313" txt_i="25089" txt_f="25090">3</offsets></td><td><offsets xml_i="35322" xml_f="35358" txt_i="25091" txt_f="25127">• Link between thoughts and feelings</offsets><break></break><offsets xml_i="35373" xml_f="35393" txt_i="25127" txt_f="25147">• Thought monitoring</offsets><break></break><offsets xml_i="35408" xml_f="35489" txt_i="25147" txt_f="25228">• Psychoeducation for written exposure and practice of writing a trauma narrative</offsets></td><td><offsets xml_i="35498" xml_f="35518" txt_i="25229" txt_f="25249">• Labelling emotions</offsets></td></tr><tr><td><offsets xml_i="35536" xml_f="35537" txt_i="25250" txt_f="25251">4</offsets></td><td><offsets xml_i="35546" xml_f="35608" txt_i="25252" txt_f="25314">• Psychoeducation and practice on reading the trauma narrative</offsets><break></break><offsets xml_i="35623" xml_f="35644" txt_i="25314" txt_f="25335">• Thought challenging</offsets></td><td><offsets xml_i="35653" xml_f="35726" txt_i="25336" txt_f="25409">• Identifying and challenging thoughts in key themes (e.g. safety, trust)</offsets></td></tr><tr><td><offsets xml_i="35744" xml_f="35745" txt_i="25410" txt_f="25411">5</offsets></td><td><offsets xml_i="35754" xml_f="35779" txt_i="25412" txt_f="25437">• Behavioural experiments</offsets><break></break><offsets xml_i="35794" xml_f="35816" txt_i="25437" txt_f="25459">• Situational exposure</offsets><break></break><offsets xml_i="35831" xml_f="35885" txt_i="25459" txt_f="25513">• Continued writing and review of the trauma narrative</offsets></td><td><offsets xml_i="35894" xml_f="35919" txt_i="25514" txt_f="25539">• Assertive communication</offsets><break></break><offsets xml_i="35934" xml_f="35976" txt_i="25539" txt_f="25581">• Extra information for family and friends</offsets><break></break><offsets xml_i="35991" xml_f="36011" txt_i="25581" txt_f="25601">• Attention shifting</offsets></td></tr><tr><td><offsets xml_i="36029" xml_f="36030" txt_i="25602" txt_f="25603">6</offsets></td><td><offsets xml_i="36039" xml_f="36058" txt_i="25604" txt_f="25623">• Key skills review</offsets><break></break><offsets xml_i="36073" xml_f="36093" txt_i="25623" txt_f="25643">• Relapse prevention</offsets></td><td><offsets xml_i="36102" xml_f="36106" txt_i="25644" txt_f="25648">None</offsets></td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec13"><title><offsets xml_i="36184" xml_f="36206" txt_i="25652" txt_f="25674">Participant monitoring</offsets></title><p><offsets xml_i="36217" xml_f="37131" txt_i="25675" txt_f="26589">The Clinical Trials Manager of CRUfAD and a member of the research team will oversee participant monitoring. Symptom severity of the target disorder and general distress levels are measured before, during, and immediately upon completing the PTSD program based on empirically validated standardised internet-delivered symptom measures. Participants will be sent automated emails at the completion of each lesson to encourage skills practice. Patient queries throughout the program are primarily addressed by email contact from the clinician (AA) or the Clinical Trials Manager (JS). If clinically indicated, or if a patient’s K10 and/or PHQ9 or PCL-C scores deteriorate, the clinician makes telephone contact. If a participant misses a lesson, a member of the research team will send an email reminder (via the Virtual Clinic system) or will make telephone contact to remind the participant to complete the lesson.</offsets></p><p><offsets xml_i="37138" xml_f="38210" txt_i="26590" txt_f="27662">The treatment group will be required to complete the iCBT program within 10 weeks to remain in the trial. Adherence is monitored throughout the program. Once enrolled, a participant can elect to discontinue at any time. A participant may be withdrawn from the trial (typically meaning course access will be closed) for the following reasons: lack of computer and internet access; change in prescribed medication for anxiety or depression; change in medication status of exclusion medications; suicidality or clinical risk; failure to complete baseline questionnaires; failure to commence the PTSD program. Lack of adherence throughout the iCBT program is not a specified reason for participant withdrawal, although a participant may withdraw voluntarily. Those in the waitlist control group will be required to complete questionnaires at weeks 1, 5 and 11 of the waitlist period to remain in the RCT. The waitlist control group will have access to the iCBT program immediately at the conclusion of the waitlist period. All reasons for withdrawal status will be documented.</offsets></p><p><offsets xml_i="38217" xml_f="38618" txt_i="27663" txt_f="28064">To promote participant retention, participants are reminded that data collection is an important aspect of research and enables the research team to track their progress and to evaluate the program. Any adverse events will be reported to the Director of CRUfAD (GA) and to the Human Research Ethics Committee (HREC) of St Vincent’s Hospital, the responsible body for initiating a clinical trial audit.</offsets></p></sec><sec id="Sec14"><title><offsets xml_i="38651" xml_f="38666" txt_i="28066" txt_f="28081">Data management</offsets></title><p><offsets xml_i="38677" xml_f="39784" txt_i="28082" txt_f="29189">All data will be collected via Virtual Clinic software and stored on a secure Virtual Clinic server. All information collected by the software is coded with either a participant identification number or an email address to facilitate data-to-patient matching. Clinical information not obtained from the online application, including diagnostic status using the MINI, is collected by interview via telephone and stored in written format in a secure location at CRUfAD. Any identifiable information collected remains confidential, except as required by law. Only members of the site (CRUfAD) research team will have access to participant information and data in order to monitor patient progress. During data analysis, re-identifiable data (i.e. coded data) will be used. At study completion, non-identifiable data will be written to a password-protected database. All data will be extracted from the Virtual Clinic servers in the form of an Excel-compatible file to be transferred to the IBM Statistical Package for the Social Sciences (IBM SPSS, IBM Corp., Armonk, NY, USA) by a member of the research team.</offsets></p><p><offsets xml_i="39791" xml_f="40047" txt_i="29190" txt_f="29446">Participants will be informed in writing that the research team plans to disseminate the trial results in peer-reviewed scientific publications and presentations. Participants are informed that in any such dissemination, their anonymity will be maintained.</offsets></p><p><offsets xml_i="40054" xml_f="40184" txt_i="29447" txt_f="29577">Participants will be sent (via email) a written summary of the results in lay terms following completion of the trial study phase.</offsets></p></sec><sec id="Sec15"><title><offsets xml_i="40217" xml_f="40236" txt_i="29579" txt_f="29598">Statistical methods</offsets></title><p><offsets xml_i="40247" xml_f="40335" txt_i="29599" txt_f="29687">Power calculations were informed by calculation of effect size data from Spence et al. [</offsets><xref ref-type="bibr" rid="CR20"><offsets xml_i="40368" xml_f="40370" txt_i="29687" txt_f="29689">20</offsets></xref><offsets xml_i="40377" xml_f="41269" txt_i="29689" txt_f="30581">], providing a between-group effect corresponding to Hedges’ g of 0.47. The minimum sample size for each group (alpha set at 0.05, power at 0.80) was identified as 72, but at least 10 % more will be recruited to hedge against expected attrition. All analyses will be conducted at conclusion of the trial period (i.e. after all participants in the treatment group have completed the iCBT program). Significance testing of group differences regarding demographic data and pre-treatment measurements will be conducted using analysis of variance (ANOVA) and χ2 where the variables consist of nominal (or categorical) data. Intent-to-treat (ITT) mixed models using restricted maximum likelihood (REML) estimation will be used to account for missing data due to participant drop-out. Mixed models do not assume that the last measurement is stable (the last observation carried forward assumption) [</offsets><xref ref-type="bibr" rid="CR63"><offsets xml_i="41302" xml_f="41304" txt_i="30581" txt_f="30583">63</offsets></xref><offsets xml_i="41311" xml_f="41407" txt_i="30583" txt_f="30679">]. REML models are appropriate for RCTs with multiple time points and pre-to post-only designs [</offsets><xref ref-type="bibr" rid="CR64"><offsets xml_i="41440" xml_f="41442" txt_i="30679" txt_f="30681">64</offsets></xref><offsets xml_i="41449" xml_f="42423" txt_i="30681" txt_f="31655">]. The assumption that data are missing at random (MAR) will be evaluated using binary logistic regression to predict drop-out (0 = no drop-out, 1 = drop-out) and by comparing these two groups on baseline measures. Significant effects will be followed up with pairwise contrasts comparing mean pre-treatment to mean post-treatment scores. Complete-case analyses of the primary hypotheses using data from participants who complete all six lessons of the PTSD program will also be conducted. The effect of potential treatment moderators (e.g. time post-trauma, number of traumatic events) will be evaluated by including baseline variables of interest as a covariate and interaction term in separate mixed models analyses. Analyses will be performed in IBM SPSS version 21. Effect sizes will be calculated between groups (Hedges’ g) and within groups (Cohen’s d, adjusting for the repeated measures correlation) using the pooled standard deviation and adjusted for sample size.</offsets></p><p><offsets xml_i="42430" xml_f="42681" txt_i="31656" txt_f="31907">Mediation analyses will be used to examine the association between change in PTSD symptoms over treatment and change in each of IU and emotion regulation in separate analyses. Tests of the indirect effects (mediation) will be conducted using PROCESS [</offsets><xref ref-type="bibr" rid="CR65"><offsets xml_i="42714" xml_f="42716" txt_i="31907" txt_f="31909">65</offsets></xref><offsets xml_i="42723" xml_f="42781" txt_i="31909" txt_f="31967">]. This method was chosen over the causal steps approach [</offsets><xref ref-type="bibr" rid="CR66"><offsets xml_i="42814" xml_f="42816" txt_i="31967" txt_f="31969">66</offsets></xref><offsets xml_i="42823" xml_f="42943" txt_i="31969" txt_f="32089">] based on recent research advocating the use of modern statistical approaches to quantify intervening variable models [</offsets><xref ref-type="bibr" rid="CR67"><offsets xml_i="42976" xml_f="42978" txt_i="32089" txt_f="32091">67</offsets></xref><offsets xml_i="42985" xml_f="43118" txt_i="32091" txt_f="32224">]. As recommended, particularly for small samples, estimates of indirect effects will be generated using bootstrapping analysis see [</offsets><xref ref-type="bibr" rid="CR68"><offsets xml_i="43151" xml_f="43153" txt_i="32224" txt_f="32226">68</offsets></xref><offsets xml_i="43160" xml_f="43162" txt_i="32226" txt_f="32228">, </offsets><xref ref-type="bibr" rid="CR69"><offsets xml_i="43195" xml_f="43197" txt_i="32228" txt_f="32230">69</offsets></xref><offsets xml_i="43204" xml_f="43756" txt_i="32230" txt_f="32782">]. Bootstrapping is a nonparametric resampling method that generates an estimate of the indirect effect, and does not require assumptions about the shape of the sampling distribution that underlie the Sobel test. In bootstrapping analysis, the most stringent test of an indirect effect (mediation) is if the 95 % bias corrected and accelerated confidence intervals for the indirect effect do not include the value of 0. When zero is outside of the 95 % confidence interval estimate, the indirect effect is declared statistically different from zero at </offsets><italic><offsets xml_i="43764" xml_f="43765" txt_i="32782" txt_f="32783">p</offsets></italic><offsets xml_i="43774" xml_f="43936" txt_i="32783" txt_f="32942"> &lt; 0.05 (two-tailed), indicating that the effect of the independent variable on the dependent variable is contingent upon the effect of the proposed mediator [</offsets><xref ref-type="bibr" rid="CR68"><offsets xml_i="43969" xml_f="43971" txt_i="32942" txt_f="32944">68</offsets></xref><offsets xml_i="43978" xml_f="44101" txt_i="32944" txt_f="33067">]. In the current study, PROCESS for SPSS will be used to estimate 5000 bias-corrected bootstrap 95 % confidence intervals.</offsets></p></sec><sec id="Sec16"><title><offsets xml_i="44134" xml_f="44158" txt_i="33069" txt_f="33093">Ethics and dissemination</offsets></title><p><offsets xml_i="44169" xml_f="44527" txt_i="33094" txt_f="33452">Staff associated with the project are aware of, and will adhere to, the National Statement on Ethical Conduct in Human Research (National Health and Medical Research Council, 2007). The current trial protocol has been approved by the Human Research Ethics Committee of St Vincent’s Hospital, Sydney, Australia. The trial is registered as ACTRN12614001213639.</offsets></p><p><offsets xml_i="44534" xml_f="44696" txt_i="33453" txt_f="33615">All members of the research team who provide intellectual input to the trial design, execution, or write-up will be acknowledged as an author on any publications.</offsets></p></sec></sec><sec id="Sec17" sec-type="discussion"><title><offsets xml_i="44757" xml_f="44767" txt_i="33618" txt_f="33628">Discussion</offsets></title><p><offsets xml_i="44778" xml_f="44901" txt_i="33629" txt_f="33752">The current RCT will test the efficacy of an iCBT intervention for PTSD. It seeks to replicate previous efficacy findings [</offsets><xref ref-type="bibr" rid="CR20"><offsets xml_i="44934" xml_f="44936" txt_i="33752" txt_f="33754">20</offsets></xref><offsets xml_i="44943" xml_f="44945" txt_i="33754" txt_f="33756">, </offsets><xref ref-type="bibr" rid="CR23"><offsets xml_i="44978" xml_f="44980" txt_i="33756" txt_f="33758">23</offsets></xref><offsets xml_i="44987" xml_f="45364" txt_i="33758" txt_f="34135">] of iCBT for PTSD in a formally assessed PTSD sample from the general population. Moreover, it will examine the relationship between PTSD symptom change following treatment and changes in IU and emotion regulation. As such, results from the proposed RCT may point to future lines of enquiry into the role of these constructs in the mechanism of PTSD symptom change during CBT.</offsets></p><p><offsets xml_i="45371" xml_f="46716" txt_i="34136" txt_f="35481">Notwithstanding the potential utility of the proposed RCT, the following potential limitations are noted. The control group in the current study is a waitlist control, rather than an active treatment control. Therefore, it will not be possible to eliminate a potential placebo effect. Moreover, the results will not speak to the relative utility of iCBT for PTSD compared to an alternative treatment approach or modality. These will be questions for future research. Further, while the trial will examine potential change in IU and emotion regulation ability, the iCBT program was not written to specifically target either of these constructs. As such, results will not permit definitive conclusions as to how treatment components impact these constructs. The current RCT will use DSM-IV PTSD diagnostic criteria and associated standardised assessment instruments, as validated DSM-5 measures were not available when recruitment began for the current project. While items reflecting the three additional DSM-5 PTSD symptoms from the PCL-5 have been included, it is important to note that formal diagnostic and associated self-report measures do not measure DSM-5 PTSD criteria specifically. We note that while having different clinicians conduct pre-treatment and follow-up interviews controls for bias, it may introduce inter-rater variability.</offsets></p><p><offsets xml_i="46723" xml_f="47001" txt_i="35482" txt_f="35760">Finally, history of child sexual and/or physical abuse is not an exclusion criterion in the current study. This approach was undertaken to maximise the generalisability of the study findings, given the prevalence of early life abuse histories in those suffering from PTSD e.g. [</offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="47033" xml_f="47034" txt_i="35760" txt_f="35761">5</offsets></xref><offsets xml_i="47041" xml_f="47284" txt_i="35761" txt_f="36004">]. It is noted that emerging evidence suggests emotion regulation skills training may be required prior to trauma-focused treatment for survivors of child trauma in order to optimise their potential benefit from trauma-focused treatment e.g. [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="47317" xml_f="47319" txt_i="36004" txt_f="36006">31</offsets></xref><offsets xml_i="47326" xml_f="47538" txt_i="36006" txt_f="36218">]. Accordingly, some national treatment guidelines suggest a period of emotion regulation or stabilisation prior to trauma-focused CBT for survivors of child abuse or other repeated/prolonged exposure to trauma [</offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="47571" xml_f="47573" txt_i="36218" txt_f="36220">10</offsets></xref><offsets xml_i="47580" xml_f="47582" txt_i="36220" txt_f="36222">, </offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="47615" xml_f="47617" txt_i="36222" txt_f="36224">11</offsets></xref><offsets xml_i="47624" xml_f="47769" txt_i="36224" txt_f="36369">]. However, there is evidence that trauma-focused treatment may have utility for such people even in the absence of emotion regulation training [</offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="47802" xml_f="47804" txt_i="36369" txt_f="36371">38</offsets></xref><offsets xml_i="47811" xml_f="47813" txt_i="36371" txt_f="36373">, </offsets><xref ref-type="bibr" rid="CR70"><offsets xml_i="47846" xml_f="47848" txt_i="36373" txt_f="36375">70</offsets></xref><offsets xml_i="47855" xml_f="47857" txt_i="36375" txt_f="36377">, </offsets><xref ref-type="bibr" rid="CR71"><offsets xml_i="47890" xml_f="47892" txt_i="36377" txt_f="36379">71</offsets></xref><offsets xml_i="47899" xml_f="47965" txt_i="36379" txt_f="36445">]. Indeed, in a treatment-seeking sample with PTSD, Jerud et al. [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="47998" xml_f="48000" txt_i="36445" txt_f="36447">32</offsets></xref><offsets xml_i="48007" xml_f="48445" txt_i="36447" txt_f="36885">] found no baseline differences in emotion regulation between those with and without history of child abuse. They further observed equivalence in improved emotion regulation between these groups following treatment, despite no prior emotion regulation training. Notwithstanding, it is acknowledged that omission of emotion regulation training may limit the potential success of the current iCBT program for some survivors of child trauma.</offsets></p></sec><sec id="Sec18"><title><offsets xml_i="48478" xml_f="48490" txt_i="36887" txt_f="36899">Trial status</offsets></title><p><offsets xml_i="48501" xml_f="48781" txt_i="36900" txt_f="37180">This article was first submitted on 19 June 2015. To date, 26 participants have met eligibility requirements. The first round of applications opened on 12 September 2014 and the first participant was enrolled on 13 September. Data collection aims to be complete in September 2016.</offsets></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ANOVA</term><def><p>Analysis of variance</p></def></def-item><def-item><term>BDI-II</term><def><p>Beck Depression Inventory – Second Edition</p></def></def-item><def-item><term>CBT</term><def><p>Cognitive behaviour therapy</p></def></def-item><def-item><term>CEQ</term><def><p>Credibility and Expectancy/Satisfaction Questionnaire</p></def></def-item><def-item><term>CRUfAD</term><def><p>Clinical Research Unit for Anxiety and Depression</p></def></def-item><def-item><term>DES</term><def><p>Dissociative Experiences Scale</p></def></def-item><def-item><term>DSM-IV</term><def><p>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</p></def></def-item><def-item><term>DSM-5</term><def><p>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</p></def></def-item><def-item><term>ERQ</term><def><p>Emotion Regulation Questionnaire</p></def></def-item><def-item><term>GAD</term><def><p>Generalised anxiety disorder</p></def></def-item><def-item><term>GAD-7</term><def><p>Generalised Anxiety Disorder 7-Item Scale</p></def></def-item><def-item><term>HREC</term><def><p>Human Research Ethics Committee</p></def></def-item><def-item><term>iCBT</term><def><p>Internet-delivered CBT</p></def></def-item><def-item><term>ITT</term><def><p>Intent-to-treat</p></def></def-item><def-item><term>IU</term><def><p>Intolerance of uncertainty</p></def></def-item><def-item><term>IUS-12</term><def><p>Intolerance of Uncertainty Scale 12-item version</p></def></def-item><def-item><term>K10</term><def><p>Kessler Psychological Distress Scale 10-item version</p></def></def-item><def-item><term>LEC-IV</term><def><p>Life Events Checklist for DSM-IV</p></def></def-item><def-item><term>LEC-5</term><def><p>Life Events Checklist for DSM-5</p></def></def-item><def-item><term>MAR</term><def><p>Missing at random</p></def></def-item><def-item><term>MINI</term><def><p>Mini International Psychiatric Interview</p></def></def-item><def-item><term>OCD</term><def><p>Obsessive compulsive disorder</p></def></def-item><def-item><term>PCL-C</term><def><p>PTSD Checklist – Civilian version</p></def></def-item><def-item><term>PCL-5</term><def><p>PTSD Checklist for DSM-5</p></def></def-item><def-item><term>PHQ-9</term><def><p>Patient Health Questionnaire 9-item version</p></def></def-item><def-item><term>PTE</term><def><p>Potentially traumatic event</p></def></def-item><def-item><term>PTSD</term><def><p>Posttraumatic stress disorder</p></def></def-item><def-item><term>RCT</term><def><p>Randomised controlled trial</p></def></def-item><def-item><term>REML</term><def><p>Restricted maximum likelihood estimation</p></def></def-item><def-item><term>SAPAS</term><def><p>Standardised Assessment of Personality – Abbreviated Scale</p></def></def-item><def-item><term>SP</term><def><p>Social phobia</p></def></def-item><def-item><term>SPIRIT</term><def><p>Standard Protocol Items: Recommendations for Interventional Trials guidelines</p></def></def-item><def-item><term>SPSS</term><def><p>Statistical Package for the Social Sciences</p></def></def-item><def-item><term>SUDOR</term><def><p>Service Utilisation and Days Out of Role Questionnaire</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors have no competing interests to declare.</p></fn><fn><p><bold>Authors’ contributions</bold></p><p>AA and GA conceived of the study and initiated the study design. JN contributed to selection of statistical analyses. AA and JN drafted the manuscript. AA and JS participated in study coordination. AA, JN, JS and GA contributed to refinement of the study protocol and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Development of the PTSD Program was supported by a grant from the Curran Foundation, St Vincent’s Hospital Sydney. This grant did not extend to study design or conduct of the RCT. JN is supported by an Australian National Health and Medical Research Council (NHMRC) Fellowship (1037787). The NHMRC had no involvement in any aspect of the study, nor the preparation of this manuscript. We thank Monika Behrens for developing the illustrations used in the PTSD program.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><source>Diagnostic and Statistical Manual of Mental Disorders</source><year>2013</year><edition>5</edition><publisher-loc>Arlington</publisher-loc><publisher-name>American Psychiatric Association</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Berglund</surname><given-names>P</given-names></name><name><surname>Demler</surname><given-names>O</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Walters</surname><given-names>EE</given-names></name></person-group><article-title>Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.62.6.593</pub-id><pub-id pub-id-type="pmid">15939837</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEvoy</surname><given-names>PM</given-names></name><name><surname>Grove</surname><given-names>R</given-names></name><name><surname>Slade</surname><given-names>T</given-names></name></person-group><article-title>Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing</article-title><source>Aust N Z J Psychiatry</source><year>2011</year><volume>45</volume><fpage>957</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.3109/00048674.2011.624083</pub-id><pub-id pub-id-type="pmid">22044173</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slade</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>D</given-names></name></person-group><article-title>The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population</article-title><source>Psychol Med</source><year>2006</year><volume>36</volume><fpage>1593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1017/S0033291706008452</pub-id><pub-id pub-id-type="pmid">16882356</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>C</given-names></name><name><surname>Mills</surname><given-names>K</given-names></name><name><surname>Slade</surname><given-names>T</given-names></name><name><surname>McFarlane</surname><given-names>AC</given-names></name><name><surname>Bryant</surname><given-names>R</given-names></name><name><surname>Creamer</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Remission from post-traumatic stress disorder in the general population</article-title><source>Psychol Med</source><year>2012</year><volume>42</volume><fpage>1695</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1017/S0033291711002856</pub-id><pub-id pub-id-type="pmid">22166813</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sareen</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>BJ</given-names></name><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Afifi</surname><given-names>TO</given-names></name><name><surname>Fleet</surname><given-names>C</given-names></name><name><surname>Asmundson</surname><given-names>GJG</given-names></name></person-group><article-title>Physical and mental comorbidity, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample</article-title><source>Psychosom Med</source><year>2007</year><volume>69</volume><fpage>242</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/PSY.0b013e31803146d8</pub-id><pub-id pub-id-type="pmid">17401056</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>KM</given-names></name><name><surname>Koenen</surname><given-names>KC</given-names></name><name><surname>Aguilar-Gaxiola</surname><given-names>S</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name><name><surname>Angermeyer</surname><given-names>MC</given-names></name><name><surname>Benjet</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Associations between lifetime traumatic events and subsequent chronic physical conditions: a cross-national, cross-sectional study</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e80573</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0080573</pub-id><pub-id pub-id-type="pmid">24348911</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zayfert</surname><given-names>C</given-names></name><name><surname>Becker</surname><given-names>CB</given-names></name><name><surname>Unger</surname><given-names>DL</given-names></name><name><surname>Shearer</surname><given-names>DK</given-names></name></person-group><article-title>Comorbid anxiety disorders in civilians seeking treatment for posttraumatic stress disorder</article-title><source>J Trauma Stress</source><year>2002</year><volume>15</volume><fpage>31</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1023/A:1014379127240</pub-id><pub-id pub-id-type="pmid">11936720</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panagioti</surname><given-names>M</given-names></name><name><surname>Gooding</surname><given-names>P</given-names></name><name><surname>Tarrier</surname><given-names>N</given-names></name></person-group><article-title>Post-traumatic stress disorder and suicidal behavior: a narrative review</article-title><source>Clin Psychol Rev</source><year>2009</year><volume>29</volume><fpage>471</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2009.05.001</pub-id><pub-id pub-id-type="pmid">19539412</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>NICE</collab></person-group><source>Post-traumatic stress disorder (PTSD): the management of PTSD in adults and children in primary and secondary care. NICE clinical guideline 26</source><year>2005</year></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Australian Centre for Posttraumatic Mental Health</collab></person-group><source>Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder</source><year>2013</year><publisher-loc>Melbourne</publisher-loc><publisher-name>ACPMH</publisher-name></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>AG</given-names></name><name><surname>Bryant</surname><given-names>RA</given-names></name><name><surname>Tarrier</surname><given-names>N</given-names></name></person-group><article-title>Cognitive behaviour therapy for posttraumatic stress disorder</article-title><source>Clin Psychol Rev</source><year>2003</year><volume>23</volume><fpage>501</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S0272-7358(03)00035-7</pub-id><pub-id pub-id-type="pmid">12729682</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>DD</given-names></name><name><surname>Marcelo Feijó</surname><given-names>M</given-names></name><name><surname>Paula</surname><given-names>V</given-names></name><name><surname>Cristiane de Medeiros</surname><given-names>P</given-names></name><name><surname>Jair de Jesus</surname><given-names>M</given-names></name></person-group><article-title>A systematic review on the effectiveness of cognitive behavioral therapy for posttraumatic stress disorder</article-title><source>Int J Psychiatry Med</source><year>2008</year><volume>38</volume><issue>3</issue><fpage>241</fpage><pub-id pub-id-type="doi">10.2190/PM.38.3.b</pub-id><pub-id pub-id-type="pmid">19069570</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponniah</surname><given-names>K</given-names></name><name><surname>Hollon</surname><given-names>SD</given-names></name></person-group><article-title>Empirically supported psychological treatments for adult acute stress disorder and posttraumatic stress disorder: a review</article-title><source>Depress Anxiety</source><year>2009</year><volume>26</volume><fpage>1086</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1002/da.20635</pub-id><pub-id pub-id-type="pmid">19957280</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>NP</given-names></name><name><surname>Kitchiner</surname><given-names>NJ</given-names></name><name><surname>Kenardy</surname><given-names>J</given-names></name><name><surname>Bisson</surname><given-names>JI</given-names></name></person-group><article-title>Systematic review and meta-analysis of multiple-session early interventions following traumatic events</article-title><source>Am J Psychiatry</source><year>2009</year><volume>166</volume><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2008.08040590</pub-id><pub-id pub-id-type="pmid">19188285</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>PS</given-names></name><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Olfson</surname><given-names>M</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Wells</surname><given-names>KB</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><fpage>629</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.62.6.629</pub-id><pub-id pub-id-type="pmid">15939840</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>CP</given-names></name><name><surname>Foa</surname><given-names>EB</given-names></name></person-group><article-title>Prolonged exposure therapy for post-traumatic stress disorder: a review of evidence and dissemination</article-title><source>Expert Rev Neurother</source><year>2011</year><volume>11</volume><fpage>1151</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1586/ern.11.94</pub-id><pub-id pub-id-type="pmid">21797656</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litz</surname><given-names>BT</given-names></name><name><surname>Engel</surname><given-names>CC</given-names></name><name><surname>Bryant</surname><given-names>RA</given-names></name><name><surname>Papa</surname><given-names>A</given-names></name></person-group><article-title>A randomized, controlled proof-of-concept trial of an Internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder</article-title><source>Am J Psychiatry</source><year>2007</year><volume>164</volume><fpage>1676</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2007.06122057</pub-id><pub-id pub-id-type="pmid">17974932</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>A</given-names></name><name><surname>Rietdijk</surname><given-names>D</given-names></name><name><surname>Hudcovicova</surname><given-names>M</given-names></name><name><surname>van de Ven</surname><given-names>JP</given-names></name><name><surname>Schrieken</surname><given-names>B</given-names></name><name><surname>Emmelkamp</surname><given-names>PM</given-names></name></person-group><article-title>Interapy: a controlled randomized trial of the standardized treatment of posttraumatic stress through the internet</article-title><source>J Consult Clin Psychol</source><year>2003</year><volume>71</volume><fpage>901</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.71.5.901</pub-id><pub-id pub-id-type="pmid">14516238</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>J</given-names></name><name><surname>Titov</surname><given-names>N</given-names></name><name><surname>Dear</surname><given-names>BF</given-names></name><name><surname>Johnston</surname><given-names>L</given-names></name><name><surname>Solley</surname><given-names>K</given-names></name><name><surname>Lorian</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Randomized controlled trial of Internet‐delivered cognitive behavioral therapy for posttraumatic stress disorder</article-title><source>Depress Anxiety</source><year>2011</year><volume>28</volume><fpage>541</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/da.20835</pub-id><pub-id pub-id-type="pmid">21721073</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>B</given-names></name><name><surname>Mitchell</surname><given-names>J</given-names></name><name><surname>Abbott</surname><given-names>J</given-names></name><name><surname>Shandley</surname><given-names>K</given-names></name><name><surname>Austin</surname><given-names>D</given-names></name><name><surname>Gilson</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>A therapist-assisted cognitive behavior therapy internet intervention for posttraumatic stress disorder: pre-, post- and 3-month follow-up results from an open trial</article-title><source>J Anxiety Disord</source><year>2010</year><volume>24</volume><fpage>635</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.janxdis.2010.04.005</pub-id><pub-id pub-id-type="pmid">20447802</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Clum</surname><given-names>GA</given-names></name></person-group><article-title>An Internet-based self-change program for traumatic event related fear, distress, and maladaptive coping</article-title><source>J Trauma Stress</source><year>2005</year><volume>18</volume><fpage>631</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/jts.20071</pub-id><pub-id pub-id-type="pmid">16382433</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knaevelsrud</surname><given-names>C</given-names></name><name><surname>Brand</surname><given-names>J</given-names></name><name><surname>Lange</surname><given-names>A</given-names></name><name><surname>Ruwaard</surname><given-names>J</given-names></name><name><surname>Wagner</surname><given-names>B</given-names></name></person-group><article-title>Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2015</year><volume>17</volume><fpage>e71</fpage><pub-id pub-id-type="doi">10.2196/jmir.3582</pub-id><pub-id pub-id-type="pmid">25799024</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEvoy</surname><given-names>PM</given-names></name><name><surname>Mahoney</surname><given-names>AE</given-names></name></person-group><article-title>To be sure, to be sure: intolerance of uncertainty mediates symptoms of various anxiety disorders and depression</article-title><source>Behav Ther</source><year>2012</year><volume>43</volume><fpage>533</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.beth.2011.02.007</pub-id><pub-id pub-id-type="pmid">22697442</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEvoy</surname><given-names>PM</given-names></name><name><surname>Mahoney</surname><given-names>AE</given-names></name></person-group><article-title>Achieving certainty about the structure of intolerance of uncertainty in a treatment-seeking sample with anxiety and depression</article-title><source>J Anxiety Disord</source><year>2011</year><volume>25</volume><fpage>112</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.janxdis.2010.08.010</pub-id><pub-id pub-id-type="pmid">20828984</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einstein</surname><given-names>DA</given-names></name></person-group><article-title>Extension of the transdiagnostic model to focus on intolerance of uncertainty: a review of the literature and implications for treatment</article-title><source>Clin Psychol</source><year>2014</year><volume>21</volume><fpage>280</fpage><lpage>300</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buhr</surname><given-names>K</given-names></name><name><surname>Dugas</surname><given-names>MJ</given-names></name></person-group><article-title>The role of fear of anxiety and intolerance of uncertainty in worry: an experimental manipulation</article-title><source>Behav Res Ther</source><year>2009</year><volume>47</volume><fpage>215</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.brat.2008.12.004</pub-id><pub-id pub-id-type="pmid">19159867</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boswell</surname><given-names>JF</given-names></name><name><surname>Thompson-Hollands</surname><given-names>J</given-names></name><name><surname>Farchione</surname><given-names>TJ</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><article-title>Intolerance of uncertainty: a common factor in the treatment of emotional disorders</article-title><source>J Clin Psychol</source><year>2013</year><volume>69</volume><fpage>630</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1002/jclp.21965</pub-id><pub-id pub-id-type="pmid">23381685</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fetzner</surname><given-names>MG</given-names></name><name><surname>Horswill</surname><given-names>SC</given-names></name><name><surname>Boelen</surname><given-names>PA</given-names></name><name><surname>Carleton</surname><given-names>RN</given-names></name></person-group><article-title>Intolerance of uncertainty and PTSD symptoms: exploring the construct relationship in a community sample with a heterogeneous trauma history</article-title><source>Cogn Ther Res</source><year>2013</year><volume>37</volume><fpage>725</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1007/s10608-013-9531-6</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>RA</given-names></name><name><surname>Mastrodomenico</surname><given-names>J</given-names></name><name><surname>Hopwood</surname><given-names>S</given-names></name><name><surname>Kenny</surname><given-names>L</given-names></name><name><surname>Cahill</surname><given-names>C</given-names></name><name><surname>Kandris</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial</article-title><source>Psychol Med</source><year>2013</year><volume>43</volume><fpage>2153</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1017/S0033291713000068</pub-id><pub-id pub-id-type="pmid">23406821</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cloitre</surname><given-names>M</given-names></name><name><surname>Stovall-McClough</surname><given-names>KC</given-names></name><name><surname>Nooner</surname><given-names>K</given-names></name><name><surname>Zorbas</surname><given-names>P</given-names></name><name><surname>Cherry</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>CL</given-names></name><etal></etal></person-group><article-title>Treatment for PTSD related to childhood abuse: a randomized controlled trial</article-title><source>Am J Psychiatry</source><year>2010</year><volume>167</volume><fpage>915</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2010.09081247</pub-id><pub-id pub-id-type="pmid">20595411</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jerud</surname><given-names>AB</given-names></name><name><surname>Zoellner</surname><given-names>LA</given-names></name><name><surname>Pruitt</surname><given-names>LD</given-names></name><name><surname>Feeny</surname><given-names>NC</given-names></name></person-group><article-title>Changes in emotion regulation in adults with and without a history of childhood abuse following posttraumatic stress disorder treatment</article-title><source>J Consult Clin Psychol</source><year>2014</year><volume>82</volume><fpage>721</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1037/a0036520</pub-id><pub-id pub-id-type="pmid">24708349</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisco</surname><given-names>BE</given-names></name><name><surname>Sloan</surname><given-names>DM</given-names></name><name><surname>Marx</surname><given-names>BP</given-names></name></person-group><article-title>Cognitive emotion regulation and written exposure therapy for posttraumatic stress disorder</article-title><source>Clin Psychol Sci</source><year>2013</year><volume>1</volume><fpage>435</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1177/2167702613486630</pub-id><pub-id pub-id-type="pmid">24482755</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>AW</given-names></name><name><surname>Tetzlaff</surname><given-names>JM</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Mann</surname><given-names>H</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><etal></etal></person-group><article-title>SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials</article-title><source>BMJ</source><year>2013</year><volume>346</volume><fpage>e7586</fpage><pub-id pub-id-type="doi">10.1136/bmj.e7586</pub-id><pub-id pub-id-type="pmid">23303884</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name></person-group><article-title>CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials</article-title><source>BMC Med</source><year>2010</year><volume>8</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/1741-7015-8-18</pub-id><pub-id pub-id-type="pmid">20334633</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisson</surname><given-names>J</given-names></name><name><surname>Andrew</surname><given-names>M</given-names></name></person-group><article-title>Psychological treatment of post-traumatic stress disorder (PTSD)</article-title><source>Cochrane Database Syst Rev</source><year>2007</year><volume>3</volume><fpage>1</fpage><lpage>46</lpage></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Friedman</surname><given-names>MJ</given-names></name><name><surname>Cohen</surname><given-names>JA</given-names></name></person-group><source>Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies</source><year>2008</year><edition>2</edition><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resick</surname><given-names>PA</given-names></name><name><surname>Galovski</surname><given-names>TE</given-names></name><name><surname>O'Brien Uhlmansiek</surname><given-names>M</given-names></name><name><surname>Scher</surname><given-names>CD</given-names></name><name><surname>Clum</surname><given-names>GA</given-names></name><name><surname>Young-Xu</surname><given-names>Y</given-names></name></person-group><article-title>A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence</article-title><source>J Consult Clin Psychol</source><year>2008</year><volume>76</volume><fpage>243</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.76.2.243</pub-id><pub-id pub-id-type="pmid">18377121</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Sheehan</surname><given-names>KH</given-names></name><name><surname>Amorim</surname><given-names>P</given-names></name><name><surname>Janavs</surname><given-names>J</given-names></name><name><surname>Weiller</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59</volume><issue>Suppl 20</issue><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9881538</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM, editors. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Proceedings in the 9<sup>th</sup> Annual Convention of the International Society for Traumatic Stress Studies; 1993 Oct 25: San Antonio, Texas.</mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at <ext-link ext-link-type="uri" xlink:href="http://www.ptsd.va.gov">www.ptsd.va.gov</ext-link>. (2013).</mixed-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>The Phq‐9</article-title><source>J Gen Intern Med</source><year>2001</year><volume>16</volume><fpage>606</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id><pub-id pub-id-type="pmid">11556941</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newby</surname><given-names>JM</given-names></name><name><surname>Mackenzie</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>AD</given-names></name><name><surname>McIntyre</surname><given-names>K</given-names></name><name><surname>Watts</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Internet cognitive behavioural therapy for mixed anxiety and depression: a randomized controlled trial and evidence of effectiveness in primary care</article-title><source>Psychol Med</source><year>2013</year><volume>43</volume><fpage>2635</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1017/S0033291713000111</pub-id><pub-id pub-id-type="pmid">23419552</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>AD</given-names></name><name><surname>Blackwell</surname><given-names>SE</given-names></name><name><surname>Mackenzie</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>EA</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name></person-group><article-title>Combining imagination and reason in the treatment of depression: a randomized controlled trial of internet-based cognitive-bias modification and internet-CBT for depression</article-title><source>J Consult Clin Psychol</source><year>2013</year><volume>81</volume><fpage>793</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1037/a0033247</pub-id><pub-id pub-id-type="pmid">23750459</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name><name><surname>Colpe</surname><given-names>LJ</given-names></name><name><surname>Hiripi</surname><given-names>E</given-names></name><name><surname>Mroczek</surname><given-names>DK</given-names></name><name><surname>Normand</surname><given-names>SL</given-names></name><etal></etal></person-group><article-title>Short screening scales to monitor population prevalences and trends in non-specific psychological distress</article-title><source>Psychol Med</source><year>2002</year><volume>32</volume><fpage>959</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1017/S0033291702006074</pub-id><pub-id pub-id-type="pmid">12214795</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderland</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Hilvert-Bruce</surname><given-names>Z</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name></person-group><article-title>Investigating trajectories of change in psychological distress amongst patients with depression and generalised anxiety disorder treated with internet cognitive behavioural therapy</article-title><source>Behav Res Ther</source><year>2012</year><volume>50</volume><fpage>374</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.brat.2012.03.005</pub-id><pub-id pub-id-type="pmid">22498311</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Löwe</surname><given-names>B</given-names></name></person-group><article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>1092</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id><pub-id pub-id-type="pmid">16717171</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löwe</surname><given-names>B</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JBW</given-names></name><name><surname>Mussell</surname><given-names>M</given-names></name><name><surname>Schellberg</surname><given-names>D</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name></person-group><article-title>Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment</article-title><source>Gen Hosp Psychiatry</source><year>2008</year><volume>30</volume><fpage>191</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2008.01.001</pub-id><pub-id pub-id-type="pmid">18433651</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carleton</surname><given-names>RN</given-names></name><name><surname>Norton</surname><given-names>MPJ</given-names></name><name><surname>Asmundson</surname><given-names>GJ</given-names></name></person-group><article-title>Fearing the unknown: a short version of the Intolerance of Uncertainty Scale</article-title><source>J Anxiety Disord</source><year>2007</year><volume>21</volume><fpage>105</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.janxdis.2006.03.014</pub-id><pub-id pub-id-type="pmid">16647833</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>JJ</given-names></name><name><surname>John</surname><given-names>OP</given-names></name></person-group><article-title>Mapping the domain of expressivity: multimethod evidence for a hierarchical model</article-title><source>J Pers Soc Psychol</source><year>1998</year><volume>74</volume><fpage>170</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.74.1.170</pub-id><pub-id pub-id-type="pmid">9457781</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>JJ</given-names></name><name><surname>John</surname><given-names>OP</given-names></name></person-group><article-title>Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being</article-title><source>J Pers Soc Psychol</source><year>2003</year><volume>85</volume><fpage>348</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.85.2.348</pub-id><pub-id pub-id-type="pmid">12916575</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>G</given-names></name></person-group><source>National Mental Health Interview</source><year>1997</year><publisher-loc>Sydney</publisher-loc><publisher-name>WHO Collaborating Centre for Mental Health and Substance AbuseSydney</publisher-name></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devilly</surname><given-names>GJ</given-names></name><name><surname>Borkovec</surname><given-names>TD</given-names></name></person-group><article-title>Psychometric properties of the credibility/expectancy questionnaire</article-title><source>J Behav Ther Exp Psychiatry</source><year>2000</year><volume>31</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/S0005-7916(00)00012-4</pub-id><pub-id pub-id-type="pmid">11132119</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blake</surname><given-names>DD</given-names></name><name><surname>Weathers</surname><given-names>FW</given-names></name><name><surname>Nagy</surname><given-names>LM</given-names></name><name><surname>Kaloupek</surname><given-names>DG</given-names></name><name><surname>Gusman</surname><given-names>FD</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><etal></etal></person-group><article-title>The development of a Clinician-Administered PTSD Scale</article-title><source>J Trauma Stress</source><year>1995</year><volume>8</volume><fpage>75</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1002/jts.2490080106</pub-id><pub-id pub-id-type="pmid">7712061</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>MJ</given-names></name><name><surname>Litz</surname><given-names>BT</given-names></name><name><surname>Hsu</surname><given-names>JL</given-names></name><name><surname>Lombardo</surname><given-names>TW</given-names></name></person-group><article-title>Psychometric properties of the life events checklist</article-title><source>Assessment</source><year>2004</year><volume>11</volume><fpage>330</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1177/1073191104269954</pub-id><pub-id pub-id-type="pmid">15486169</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Weathers</surname><given-names>FW</given-names></name><name><surname>Blake</surname><given-names>DD</given-names></name><name><surname>Schnurr</surname><given-names>PP</given-names></name><name><surname>Kaloupek</surname><given-names>DG</given-names></name><name><surname>Marx</surname><given-names>BP</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name></person-group><source>The Life Events Checklist for DSM-5 (LEC-5)</source><year>2013</year></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>GK</given-names></name></person-group><source>Manual for the Beck Depression Inventory (second edition)</source><year>1996</year><publisher-loc>San Antonio, TX</publisher-loc><publisher-name>Psychological Corporation</publisher-name></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>EB</given-names></name><name><surname>Putnam</surname><given-names>FW</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Torem</surname><given-names>M</given-names></name><name><surname>Coons</surname><given-names>P</given-names></name><name><surname>Dill</surname><given-names>DL</given-names></name><etal></etal></person-group><article-title>Validity of the Dissociative Experiences Scale in screening for multiple personality disorder: a multicenter study</article-title><source>Am J Psychiatry</source><year>1993</year><volume>150</volume><fpage>1030</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1176/ajp.150.7.1030</pub-id><pub-id pub-id-type="pmid">8317572</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubester</surname><given-names>KA</given-names></name><name><surname>Braun</surname><given-names>BG</given-names></name></person-group><article-title>Psychometric properties of the Dissociative Experiences Scale</article-title><source>J Nerv Ment Dis</source><year>1995</year><volume>183</volume><fpage>231</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1097/00005053-199504000-00008</pub-id><pub-id pub-id-type="pmid">7714511</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarrett</surname><given-names>RB</given-names></name><name><surname>Vittengl</surname><given-names>JR</given-names></name><name><surname>Clark</surname><given-names>LA</given-names></name><name><surname>Thase</surname><given-names>ME</given-names></name></person-group><article-title></article-title><source>Psychol Assess</source><year>2011</year><volume>23</volume><fpage>578</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1037/a0022485</pub-id><pub-id pub-id-type="pmid">21319902</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>P</given-names></name><name><surname>Leese</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Walters</surname><given-names>P</given-names></name><name><surname>Thornicroft</surname><given-names>G</given-names></name><name><surname>Mann</surname><given-names>A</given-names></name></person-group><article-title>Standardised Assessment of Personality – Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder</article-title><source>Br J Psychiatry</source><year>2003</year><volume>183</volume><fpage>228</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1192/bjp.183.3.228</pub-id><pub-id pub-id-type="pmid">12948996</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>G</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><name><surname>McEvoy</surname><given-names>P</given-names></name><name><surname>Titov</surname><given-names>N</given-names></name></person-group><article-title>Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e13196</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0013196</pub-id><pub-id pub-id-type="pmid">20967242</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueorguieva</surname><given-names>R</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group><article-title>Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry</article-title><source>Arch Gen Psychiatry</source><year>2004</year><volume>61</volume><fpage>310</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.61.3.310</pub-id><pub-id pub-id-type="pmid">14993119</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>A</given-names></name><name><surname>Mackinnon</surname><given-names>A</given-names></name><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Griffiths</surname><given-names>K</given-names></name></person-group><article-title>Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates</article-title><source>Psychiatry Res</source><year>2008</year><volume>160</volume><fpage>335</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.psychres.2007.08.005</pub-id><pub-id pub-id-type="pmid">18718673</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>AF</given-names></name></person-group><source>Introduction to mediation, moderation, and conditional process analysis: A regression-based approach</source><year>2013</year><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>RM</given-names></name><name><surname>Kenny</surname><given-names>DA</given-names></name></person-group><article-title>The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations</article-title><source>J Pers Soc Psychol</source><year>1986</year><volume>51</volume><fpage>1173</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.51.6.1173</pub-id><pub-id pub-id-type="pmid">3806354</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>AF</given-names></name></person-group><article-title>Beyond Baron and Kenny: Statistical mediation analysis in the new millennium</article-title><source>Commun Monogr</source><year>2009</year><volume>76</volume><fpage>408</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1080/03637750903310360</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preacher</surname><given-names>KJ</given-names></name><name><surname>Hayes</surname><given-names>AF</given-names></name></person-group><article-title>Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models</article-title><source>Behav Res Methods</source><year>2008</year><volume>40</volume><fpage>879</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.3758/BRM.40.3.879</pub-id><pub-id pub-id-type="pmid">18697684</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Mackinnon</surname><given-names>D</given-names></name></person-group><article-title>Resampling and distribution of the product methods for testing indirect effects in complex models</article-title><source>Struct Equ Model</source><year>2008</year><volume>15</volume><fpage>23</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1080/10705510701758166</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chard</surname><given-names>KM</given-names></name></person-group><article-title>An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse</article-title><source>J Consult Clin Psychol</source><year>2005</year><volume>73</volume><fpage>965</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.73.5.965</pub-id><pub-id pub-id-type="pmid">16287396</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonagh</surname><given-names>A</given-names></name><name><surname>Friedman</surname><given-names>M</given-names></name><name><surname>McHugo</surname><given-names>G</given-names></name><name><surname>Ford</surname><given-names>J</given-names></name><name><surname>Sengupta</surname><given-names>A</given-names></name><name><surname>Mueser</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse</article-title><source>J Consult Clin Psychol</source><year>2005</year><volume>73</volume><fpage>515</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.73.3.515</pub-id><pub-id pub-id-type="pmid">15982149</pub-id></element-citation></ref></ref-list></back></article>